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Abstract: The subject of this review is the biodiversity of marine sponges and associated 
microbes which have been reported to produce therapeutically important compounds, along 
with the contextual information on their geographic distribution. Class Demospongiae and 
the orders Halichondrida, Poecilosclerida and Dictyoceratida are the richest sources of 
these compounds. Among the microbial associates, members of the bacterial phylum 
Actinobacteria and fungal division Ascomycota have been identified to be the dominant 
producers of therapeutics. Though the number of bacterial associates outnumber the fungal 
associates, the documented potential of fungi to produce clinically active compounds is 
currently more important than that of bacteria. Interestingly, production of a few identical 
compounds by entirely different host-microbial associations has been detected in both 
terrestrial and marine environments. In the Demospongiae, microbial association is highly 
specific and so to the production of compounds. Besides, persistent production of bioactive 
compounds has also been encountered in highly specific host-symbiont associations. 
Though spatial and temporal variations are known to have a marked effect on the quality 
and quantity of bioactive compounds, only a few studies have covered these dimensions. 
The need to augment production of these compounds through tissue culture and 
mariculture has also been stressed. The reviewed database of these compounds is available 
at www.niobioinformatics.in/drug.php. 
Keywords: marine drugs; sponges; microbial symbionts; bioactive compounds 
 
OPEN ACCESSMar. Drugs 2010, 8                 
 
1418
1. Introduction 
Sponges (Phylum: Porifera) are evolutionarily ancient metazoans
  that have existed for   
700–800 million years. They not only populate the tropical oceans in great abundance but also
 occur in 
temperate waters and even in freshwater [1,2]. Marine sponges are widely distributed from intertidal 
zones to thousands of meters deep in the ocean [3]. They are simple multicellular invertebrates 
attached to solid substrates in benthic habitats. Sponges are filter feeders, having numerous tiny pores 
on their surface, which allow water to enter and circulate through a series of canals where 
microorganisms and organic particles are filtered out and eaten [4]. There are mainly three classes of 
sponges, namely the Calcarea (five orders and 24 families), Demospongiae (15 orders and 92 families) 
and Hexactinellida (six orders and 20 families). So far about 15,000 species of sponges have been 
described, but their true diversity may be higher [5]. Most of them occur in the marine environment 
and only about 1% inhabit freshwater [6]. Most of the species are placed under the class 
Demospongiae. Since sponges are simple and sessile organisms; during evolution they have developed 
potent chemical defensive mechanism to protect themselves from competitors and predators as well as 
infectious microorganisms. Studies show that secondary metabolites in sponges play a crucial role in 
their survival in the marine ecosystem [7]. These natural products have interesting biomedical 
potential, pharmaceutical relevance and diverse biotechnological applications [4,8–13]. The 
biomedical and pharmaceutical importances of these compounds are attributed to their antiviral, 
antitumor, antimicrobial and general cytotoxic properties [14]. Interestingly, out of the 13 marine 
natural products that are currently under clinical trials as new drug candidates, 12 are derived from 
invertebrates. Among them, Porifera remains the most important phylum, as it provides a greater 
number of natural products, especially novel pharmacologically active compounds [15,16]. 
Biochemical characteristics seem to be useful taxonomic markers and good indicators of sponge 
phylogeny [17]. The diversity of biochemical properties of sponges has been demonstrated by the 
continued discovery of novel compounds, having pharmacological properties [18]. These 
investigations started with the pioneering work of Bergmann on the extraction of novel bioactive 
nucleosides from the sponge Tectitethya crypta (formerly Cryptotethya crypta) [19]. The chemical 
diversity of secondary metabolites isolated from sponges includes amino acids, nucleosides, 
macrolides, porphyrins, terpenoids, aliphatic cyclic peroxides and sterols [7]. Sponges are well known 
to be hosts for a large community of microorganisms, which comprise a significant percentage (up to 
50–60%) of the biomass of the sponge host [20,21]. The role of these diverse microbes in sponge 
biology varies from source of nutrition to mutualistic symbiosis with the sponge [22]. Based on 
bacterial community studies employing molecular methods such as Denaturing Gradient Gel 
Electrophoresis (DGGE), 16S rRNA gene sequencing and Fluorescence In Situ Hybridization (FISH), 
it has been recognized that the sponge-associated bacterial community consists of at least ten bacterial 
phyla such as Proteobacteria, Nitrospira, Cyanobacteria, Bacteriodetes, Actinobacteria, Chloroflexi, 
Planctomycetes, Acidobacteria, Poribacteria and Verrucomicrobia  besides members of the domain 
Archaea [1,23–30]. Other symbiotic microbial populations that inhabit sponges are fungi and 
microalgae. Little is known about viruses in sponges, although virus-like particles have been observed 
in cell nuclei of Aplysina (Verongia) cavernicola [32]. There are two pathways through which a 
developing sponge acquires bacterial symbionts. The first one is by selective absorption of specific Mar. Drugs 2010, 8                 
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bacteria from the large diversity of bacteria in the surrounding water column that passes through the 
sponge during filter feeding. The second one is by vertical transmission of symbionts through the 
gametes of the sponge by inclusion of the bacteria in the oocytes or larvae [33].  
Symbiotic functions that have been attributed to microbial associates include nutrient acquisition, 
stabilization of sponge skeleton, processing of metabolic waste and secondary metabolite production 
[1]. It is hypothesized that symbiotic marine microorganism harboured by sponges are the original 
producers of these bioactive compounds [12,33–35]. The first experimental evidence supporting this 
hypothesis was derived from the work of Faulkner et al. [27], who investigated the localization of 
natural products within sponge-microorganism association. For this purpose, cell populations within 
sponge samples were separated by differential centrifugation and the fractions obtained were analyzed 
chemically. By this approach, it was possible to locate the cytotoxic macrolide swinholide A and the 
peptide theopalauamide in the heterotrophic unicellular bacteria and in the filamentous heterotrophic 
bacteria, respectively. Both the bacterial strains were isolated from the sponge Theonella swinhoei. 
Microbial associates of sponges gained significance as source of bioactive compounds only when a 
remarkable similarity was found between those compounds isolated predominantly from sponges and 
those found in terrestrial organism of entirely different taxa [36]. Likewise, similarities between the 
structures of mycalamide A & B from the marine sponge Mycale hentscheli, collected in Dunedin 
Harbour (New Zealand) and pederin, a toxin originally isolated from the Paederus beetle in South 
America was recognized by Perry et al. [37]. Mycalamides have been reported to be potent inhibitors 
of protein synthesis and were recently found to cause apoptosis [38]. Thus, it indicates that at least 
some of the bioactive secondary metabolites isolated from sponges are produced by functional enzyme 
clusters, originated from the sponges and/or their associated microorganisms [39]. It is now known that 
polybrominated biphenyl ether antibiotics isolated from the sponge Dysidea herbacea (Demospongiae) 
are actually produced by the endosymbiotic cyanobacterium Oscillatoria spongeliae [35,40]. 
Molecular methods (e.g; rDNA, DGGE and FISH) have revealed the association of a variety of 
unculturable bacteria and Archaea in sponges. It has recently been demonstrated that sponge isolates 
with antimicrobial activity are numerically very abundant in the genus Pseudoalteromonas and the 
group of α-Proteobacteria [7,41] and Actinobacteria [42]. As infectious microorganisms evolve and 
develop resistance to existing pharmaceuticals, marine sponges provide novel leads against bacterial, 
viral, fungal and parasitic diseases [39]. Thus, it is extremely relevant to highlight the therapeutic 
properties of various secondary metabolites synthesized by the microbial flora inhabiting sponges. In 
this review, an effort has been made to relate the biomedical significance of secondary metabolites of 
sponge-microbial association, which were discovered so far and their richness in different sponge taxa. 
It is also important to understand their ecological distribution in space and time so as to enable 
harnessing these compounds in an optimal and sustainable manner. Mar. Drugs 2010, 8                 
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Table1. Current status of species producing clinically active compounds in association 
with microbes. 
Class: Demospongiae 
Order Family  Species    Reference 
Astrophorida Ancorinidae Stelletta tenuis  [23,42] 
Jaspis aff. johnstoni  [43–45] 
Chondrosida Chondrillidae  Chondrosia reniformis  [46–48] 
Dendroceratida Darwinellidae Dendrilla nigra [50–53] 
Dictyoceratida Dysideidae  Lamellodysidea herbacea  [40,57] 
   Dysidea sp.  [59] 
   Dysidea avara  [61,62] 
 Irciniidae  Ircinia fasciculata  [33,64,65] 
 Spongiidae  Hyatella sp.  [66] 
   Spongia sp.  [69] 
 Thorectidae  Hyrtios altum  [70–72] 
   Hyrtios sp.  [45,73] 
   Hyrtios proteus  [75] 
   Fascaplysinopsis reticulata  [48,76] 
Hadromerida Spirastrellidae  Spirastrella vagabunda [77,78] 
 Suberitidae  Suberites domuncula [15,79] 
Halichondrida Axinellidae  Ptilocaulis trachys  [81,82] 
   Axinella sp. 1  [82] 
   Axinella sp. 2  [84] 
   Axinella verrucosa  [85–87] 
   Axinella damicornis  [88] 
   Axinella sp. 3  [89] 
 Halichondriidae  Halichondria okadai [78,93–97] 
   Halichondria panacea  [100,101] 
   Halichondria japonica  [79,102,104,109–113] 
   Acanthella acuta  [116] 
   Hymeniacidon perlevis  [43,44,117] 
Haplosclerida Callyspongiidae  Callyspongia aerizusa [118] 
   Callyspongia vaginalis  [119,120] 
 Chalinidae  Haliclona valliculata  [121] 
   Haliclona simulans  [25] 
   Haliclona sp. 1  [123] 
   Haliclona sp. 2  [2] 
 Niphatidae  Niphates olemda  [124,125] 
 Petrosiidae  Petrosia ficiformis  [129–131] 
   Xestospongia sp.  [133] 
   Xestospongia exigua  [79,124,134,135] 
   Acanthostrongylohpora sp.  [82] 
   Petrosia sp.  [139–141] 
Lithistida Neopeltidae  Homophymia sp. [142] 
 Theonellidae  Theonella swinhoei [145–148,150] 
 Mar. Drugs 2010, 8                 
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Table 1. Cont. 
Poecilosclerida Acarnidae  Zyzzya sp. [151,152] 
 Isodictyidae  Isodictya setifera  [153] 
 Raspailiidae  Ectyoplasia ferox [154] 
 Mycalidae  Mycale plumose [159,160] 
   Mycale adhaerens  [48,162] 
 Myxillidae  Myxilla incrustance [79,158] 
Spirophorida Tetillidae  Craniella australiensis [163] 
Verongida Aplysinellidae  Suberea clavata [167] 
 Aplysinidae  Aplysina aerophoba  [170,174] 
   Aplysina cavernicola  [41] 
 Pseudoceratinidae  Pseudoceratina purpurea  [90] 
Class: Calcarea 
 Leucettidae  Leucetta microraphis [120] 
 
No bioactive compounds have been reported from microbes associated with sponge families such as 
Agelasidae, Astroscleridae, Calthropellidae, Geodiidae, Pachastrellidae, Thrombidae, 
Dictyodendrillidae, Acanthochaetetidae, Alectonidae, Hemiasterellidae, Placospongiidae, 
Polymastiidae, Spirastrellidae, Stylocordylidae, Tethyidae, Timeidae, Trachycladidae, Bubaridae, 
Dictyonellidae, Heteroxyidae, Halisarcidae, Calcifibrospongiidae, Phloeodictyidae, Lubomirskiidae, 
Malawispongiidae, Metaniidae, Metschnikowiidae, Palaeospongillidae, Potamolepiidae, Spongillidae, 
Spongillina incertae sedis, Plakinidae, Azoricidae, Corallistidae, Desmanthidae, Isoraphiniidae, 
Lithistida incertae sedis, Macandrewiidae, Phymaraphiniidae, Phymatellidae, Pleromidae, 
Scleritodermidae, Siphonidiidae, Vetulinidae, Latrunculiidae, Microcionidae, Rhabderemiidae, 
Cladorhizidae, Desmacellidae, Esperiopsidae, Guitarridae, Hamacanthidae, Merliidae, 
Podospongiidae, Chondropsidae, Coelosphaeridae, Crambeidae, Crellidae, Dendoricellidae, 
Desmacididae, Hymedesmiidae, Iotrochotidae, Phellodermidae, Tedaniidae, Samidae and 
Spirasigmidae of the class Demospongiae; Baeriidae, Lepidoleuconidae, Trichogypsiidae, 
Achramorphidae, Amphoriscidae, Grantiidae, Heteropiidae, Jenkinidae, Lelapiidae, Leucosoleniidae, 
Sycanthidae, Sycettidae, Minchinellidae, Petrobionidae, Clathrinida incertae sedis, Clathrinidae, 
Leucaltidae, Leucascidae, Levinellidae, Soleneiscidae, Lelapiellidae, Murrayonidae, Paramurrayonidae 
of the class Calcarea. There are no reports of microbially originated bioactive compounds from the 
class Hexactinellida. 
2. Sponges and Associated Microbes Involved in Drug Production 
2.1. Class: Demospongiae 
2.1.1. Order: Astrophorida 
Family: Ancorinidae 
L,L-Diketopiperazine known as cyclo-(L-Pro-L-Phe), showing moderate antimicrobial activity was 
isolated from the bacterium Alcaligenes faecalis A72, which was found in association with the South Mar. Drugs 2010, 8                 
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China Sea sponge Stelletta tenuis [42]. The sponge Stelletta tenuis is known for harbouring large 
number of cultivable bacterial diversity, including α-, γ-, δ- Proteobacteria, Bacteroidetes, Firmicutes 
and Actinobacteria [23,42]. A marine fungus of the class Hyphomycetes was isolated from the Indo-
Pacific sponge Jaspis aff. johnstoni. Fermentation of this marine culture led to the isolation of the 
tricyclic sesquiterpenes coriolin B, dihydrocoriolin C as well as the novel chloriolines A-C. Coriolin B 
and dihydrocoriolin C were earlier isolated from the terrestrial wood-rotting basidiomycete Coriolus 
consors. Coriolin B exhibited strong inhibition of human breast and CNS cell lines with IC50 values of 
0.7 µg (breast) and 0.5 µg (neuroblastoma) [9,43–45].  
2.1.2. Order: Chondrosida 
Family: Chondrillidae 
Seven new fungal polyketides were isolated from the mycelium extract of the fungus Penicillium 
rugulosum, derived from the sponge Chondrosia reniformis (Elba, Italy). They include prugosenes 
A1–A3, B1, B2, C1 and C2. These compounds can be used as templates for new   
anti-infectives [46–48]. 
2.1.3. Order: Dendroceratida 
Family: Darwinellidae 
The sponge Dendrilla nigra is a rich source of cultivable marine actinomycetes. Investigations on a 
sponge specimen collected from the Vizhinjam coast (west coast of India) revealed that 
Micromonospora-Saccharomonospora-Streptomyces  group was the major cultivable actinobacteria 
found in the sponge [49]. The species Streptomyces dendra sp. nov. MSI051 isolated from Dendrilla 
nigra from the same coast exhibited a broad spectrum of antibacterial activity. The host sponge, as 
well as the associated bacterial symbiont MSI051, contained high levels of PLA2 (Phospholipase A2) 
[50]. Since PLA2 is a well-established antibacterial protein in the defense system of higher animals, its 
presence in the sponge-associated bacteria may indicate an integrated functional role in the host 
defense system [51]. Another strain, Streptomyces sp. BLT7 isolated from Dendrilla nigra obtained 
from Kanyakumari (south east coast of India) also showed potential antibacterial activity in their 
extracellular products [52,53]. A number of actinobacterial strains were also obtained from Dendrilla 
nigra, collected from the southwest coast of India. Among eleven heterotrophic actinobacteria isolated 
from one specimen, Nocardiopsis dassonvillei MAD08 was prominent in its antibacterial and 
anticandidal activity against the multidrug resistant pathogenic microbial strains. The antibacterial 
activity was assigned to the presence of 11 compounds and the anticandidal activity to a single protein. 
The uniqueness of this strain is reflected in the expression of both organic solvent (antibacterial) and 
water soluble (antifungal) antimicrobial compounds. In future, this may lead the way towards large-
scale profitable production of antimicrobials from Nocardiopsis dassonvillei MAD08 [53]. The above 
studies reflect the consistent production of antimicrobial compounds by the actinobacteria harbouring 
individuals of Dendrilla nigra from south west coast of India.  
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2.1.4. Order: Dictyoceratida 
2.1.4.1. Family: Dysideidae 
Many marine sponges, especially the tropical ones, form symbioses with algae and often become 
net primary producers. Although associations with cyanobacteria are the most common, such 
partnership has also been observed with chlorophytes, rhodophytes, dinoflagellates and diatoms 
[54,55]. A variety of marine sponges hold cyanobacteria as autotrophic symbionts, which are known to 
contribute to nutrition of host through extracellular lysis and phagocytosis, with possible glycogen re-
utilization by sponge cells. Cyanobacteria transfer glycerol and organic phosphate to sponge tissue, as 
derivatives of these compounds are known to support several basic metabolic pathways. Moreover, 
symbiotic cyanobacteria appear to be capable of fixing nitrogen [55]. The tropical marine shallow 
water sponge Lamellodysidea herbacea (formerly Dysidea herbacea) which is common throughout the 
Indo-Pacific, is always found to harbour filamentous non-heterocystous cyanobacterium Oscillatoria 
spongeliae. It occurs intercellularly in large numbers up to 20% of the symbiotic associations’ volume 
and 30–50% of the sponge tissue volume [10,57]. These cyanobacterial symbionts have been reported 
to be responsible for the production of a wide array of secondary metabolites by the sponge [55]. 
Nuclear magnetic resonance analysis of the symbiont cell preparations from the specimen of 
Lamellodysidea herbacea obtained from Great Barrier Reef, Australia showed that they usually 
contain the chlorinated diketopiperazines, dihydrodysamide C and didechlorodihydrodysamide C, 
which are characteristic metabolites of the sponge-symbiont association [56,57]. Since 
diketopiperazines (DKPs) are a common motif in various biologically active natural products, they 
may be useful scaffolds for the rational design of receptor probes and therapeutic agents [58]. 
Symbiotic microorganisms of Dysidea sp. can synthesize physiologically active compounds which 
belong to the group of brominated diphenyl ethers. Vibrio  sp. associated with Dysidea specimen 
collected near the islands of Tutuila and Ofu (Eastern Samoa) synthesize cytotoxic and antibacterial 
tetrabromodiphenyl ethers [59]. A specimen of Lamellodysidea herbacea collected from the Republic 
of Palau (Caroline Island, Western Pacific Ocean) yielded a polybrominated biphenyl ether such as  
2-(2',4'-dibromophenyl)-4,6-dibromophenol. The compound was deposited as conspicuous crystals 
throughout the sponge tissue. The cyanobacteria Oscillatoria spongeliae was also observed as 
endosymbiont in the sponge mesohyl. They were separated from the sponge cells and heterotrophic 
bacteria by flow cytometry. Coupled gas chromatography-mass spectrometry and protein nuclear 
magnetic resonance revealed that the real source of the compound was the cyanobacteria Oscillatoria 
spongeliae. The polybrominated metabolites produced by the cyanobacteria are excreted into the 
surrounding aqueous medium in which they are not soluble, and therefore crystallize. Thus 
considerable amount of brominated metabolites are seen as crystalline material in the sponge mesohyl, 
with only a relatively small amount in the cyanobacteria. Polybrominated biphenyl ethers from 
Lamellodysidea herbacea are active against both Gram-, Gram+ bacteria and unicellular marine 
cyanobacteria. The compound, 2-(2',4'-dibromophenyl)-4,6-dibromophenol showed antibacterial 
activity against Staphylococcus aureus, Escherichia coli, Bacillus subtilis etc. The apparent general 
toxicity of polybrominated compounds particularly to prokaryotes is beneficial to the association 
Lamellodysidea herbacea-  Oscillatoria spongeliae. This association is more resistant to these Mar. Drugs 2010, 8                 
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compounds [40]. Lamellodysidea herbacea is one of the established model systems for addressing the 
question as to whether sponge metabolites are produced by the symbiotic bacterium or the host itself 
[60]. An unknown bacterium associated with the marine sponge Dysidea avara, collected from 
Adriatic Sea was found to produce the compound 2-methylthio-1,4-naphthoquinone. This compound 
showed strong antiangiogenic and antimicrobial properties [61]. 16S rDNA analysis revealed that the 
bacterial strain shares 99% identity to the α-Proteobacteria MBIC3368 [62]. 
2.1.4.2. Family: Irciniidae 
Marine sponges in the genus Ircinia are known to be good sources of secondary metabolites having 
biological activities [61,63,64]. The species Ircinia fasciculata, collected from the shallow coastal 
habitats of the Mediterranean Sea (~15 m depth) showed antimicrobial activity in the agar media 
inoculated with different indicator organisms such as Escherichia coli, Staphylococcus lentus, Candida 
sp., Bacillus subtilis and Mycobacterium sp. The sponge specimen was chosen for the isolation of 
bacteria, on the basis of the accumulated evidence that microorganism could well be the true source for 
some of the metabolites produced by sponges. γ- Proteobacteria was detected in the sponge isolate 
[32]. An antileukemic marine natural product, sorbicillactone A was isolated from the salt water 
culture of the fungus Penicillium chrysogenum obtained from another Mediterranean specimen of 
Ircinia fasciculata. It possesses a unique bicyclic lactone structure, seemingly derived from sorbicillin. 
The compound exhibited promising activities in several mammalian and viral test systems, particularly 
in a highly selective cytostatic activity against murine leukemic lymphoblasts (L5178y) and also 
showed the ability to protect human T cells against the cytopathic effects of HIV-1. These properties 
qualify sorbicillactone A for future therapeutic human trials [64,65]. 
2.1.4.3. Family: Spongiidae 
An antibacillus compound, which was chemically identified as the peptide antibiotic andrimid was 
detected in the extract of the sponge Hyatella sp. A bacterial isolate M22-1, belonging to the genus 
Vibrio was also isolated from the homogenate of the same sponge. The bacterium when cultured in 
marine agar also produced the same compound. This suggests that the origin of andrimid in the sponge 
is from the bacterium [66]. Andrimid previously isolated from the cultures of an Enterobacter sp. 
which is an intracellular symbiont of the brown plant hopper Nilaparvata lugens and was found to 
exhibit potent activity against Xanthomonas campestris pv. oryzae [67]. It has also been isolated from 
marine  Pseudomonas fluorescens, which was active against methicillin-resistant Staphylococcus 
aureus. Due to the diversity of the microorganism producing this toxin, one can speculate that the 
production of this compound might be encoded by genes transferable on a plasmid [68]. The culture 
broth extracts of the fungus, Myrothecium verrucaria 973023 which was separated from Spongia sp. of 
Hawaii, showed potent activity against murine lymphocytic leukemia L1210 and human colon tumor 
H116 cell lines in the soft agar-based bioassay system. Further studies indicated the presence of three 
new trichothecenes, viz. 3-hydroxyroridin E, 13’-acetyltrichoverrin B, miophytocen C and nine known 
related compounds such as roridin A, L, M, isororidin A, epiroridin E, verrucarin A, M, trichoverrin A 
and B in the extract. All the compounds except miophytocen C showed significant cytotoxicity against 
murine and human tumor cell lines [69]. Mar. Drugs 2010, 8                 
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2.1.4.4. Family: Thorectidae 
A new antibiotic trisindole derivative, viz. trisindoline, has been characterized from a marine Vibrio 
sp., which was separated from the fresh marine okinawan sponge Hyrtios altum. Trisindoline was 
shown to exhibit potential antibiotic activity against Escherichia coli,  Bacillus subtilis and 
Staphylococcus aureus [70–72]. An antileukemic compound, asperazine was isolated from the 
saltwater culture of the fungus Aspergillus niger obtained from a caribbean Hyrtios sponge by Crews 
et al. [73]. Asperazine is a member of a large family of diketopiperazine alkaloids. Asperazine 
displayed remarkable cytotoxicity and an interesting leukemia selectivity [45,74]. Culture extract of 
another strain of Aspergillus niger from the sponge Hyrtios proteus (Dry Tortugas National Park, 
Florida) displayed broad chemodiversity and five compounds belonging to a wide range of 
biosynthetic classes were isolated. Among them, malformin C and asperazine displayed tumor and 
leukemia selective bioactivity [75]. From the above findings, it can be deduced that Aspergillus niger 
associated with two different species of Hyrtios inhabiting different geographical locations is capable 
of producing asperazine. It also gives insight in to the adaptability of a particular microbial associate to 
a particular sponge genus. An epibiotic bacterial strain Pseudoalteromonas maricaloris KMM 636T, 
isolated from the Great Barrier Reef sponge Fascaplysinopsis reticulata was the source of two 
brominated chromopeptides such as bromoalterochromide A and bromoalterochromide A . They 
showed moderate cytotoxicity to the eggs of the sea urchin Strongylocentrotus intermedius [48,76]. 
2.1.5. Order: Hadromerida 
2.1.5.1. Family: Spirastrellidae 
A polyketide, 14,15-secocurvularin was isolated from the saltwater culture of an unidentified 
fungus obtained from an Indonesian encrusting sponge Spirastrella vagabunda [77]. It was described 
as being mildly antibiotic against Bacillus subtilis when compared to tetracycline [78]. 
2.1.5.2. Family: Suberitidae 
Suberites domuncula is yet another excellent source for the recovery of bacteria having bioactive 
potential. This sponge typically grows on snail shells and has a compact, smooth, waxy and colorful 
surface. Bacteria were isolated from the sponge surface as well as from the laboratory-developed 
primmorphs of Suberites domuncula collected from northern Adriatic Sea. Two bacteria isolated from 
the sponge surface were identified as α-Proteobacterium MBIC3368 by using 16S rDNA sequences 
[79]. This bacterium has also been isolated from several other sponges (e.g., Rhopaloeides odorabile, 
Aplysina aerophoba) regardless of their taxonomic identity, geographic location or natural product 
profile [30,40]. Another bacterial isolate from the sponge surface showed 98.8% species level 
similarity to Idiomarina loihiensis (Alteromonadaceae). The bacteria on primmorph represented 
unidentified novel species of Pseudomonas [79]. Bioactive extracts of α-Proteobacterial strains from 
the sponge surface as well as Pseudomonas sp. associated with primmorph exhibited antiangiogenic, 
antimicrobial, hemolytic and cytotoxic properties. These bacterial extracts were strongly active against Mar. Drugs 2010, 8                 
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multidrug-resistant clinical strains of Staphylococcus aureus and Staphylococcus epidermidis, isolated 
from hospital patients. Extracts from Idiomarina species also showed hemolytic activity [15]. 
2.1.6. Order: Halichondrida 
2.1.6.1. Family: Axinellidae 
A cyclic depsipeptide, majusculamide C has been isolated from the metabolites of the sponge 
Ptilocaulis trachys collected at the Enewetak Atoll (Marshall Island, Pacific Ocean). It was originally 
isolated from the toxic blue-green alga Lyngbya majuscula obtained from the same site. 
Majusculamide C exhibited antifungal activity against pathogens of commercially important plants. 
This discovery proved that accumulation of cyanobacteria in sponges is diet derived [81,82]. A 
symbiotic fungal strain Myrothecium sp. JS9 in the marine sponge Axinella sp. from South China Sea 
was found to be an efficient producer of most effective antifungal metabolites roridin A and D 
(macrocyclic trichothecenes). Biologically, this class of compounds was reported to possess 
antileukemic, antimalarial, antimicrobial, phytotoxic and cytotoxic properties [83]. Structurally unique 
steroids, isocyclocitrinols A and 22-acetylisocyclocitrinol A were isolated from the extract of a 
saltwater culture of sponge derived fungus Penicillium citrinum, separated from the sponge Axinella 
sp., collected in Papua New Guinea. Both the steroid compounds exhibited weak antibacterial activity 
against  Staphylococcus epidermidis and Enterococcus durans [84]. The ethyl acetate extract of 
Penicillium  sp., derived from the Mediterranean sponge Axinella verrucosa, yielded the known 
compound communesin B and its new congeners communesins C and D, and the known compounds 
oxaline, griseofulvin and dechlorogriseofulvin. Oxaline is an antiproliferative agent which inhibits 
microtubule protein/ purified tubulin polymerization, resulting in arresting cell cycle at the M-phase 
[85]. Griseofulvin is a widely used antifungal agent for the treatment of superficial dermatomycoses 
[86]. In several bioassays performed on different leukemia cell lines, the communesins exhibited 
moderate antiproliferative activity [87]. From a static culture of the fungal strain Aspergillus niger 
isolated from the Mediterranean sponge Axinella damicornis, eight secondary metabolites belonging to 
four entirely different structural classes were obtained. Among these, the new compound   
3,3’-bicoumarin (bicoumanigrin A) showed moderate cytotoxicity against human cancer cell lines in 
vitro. Another compound, aspernigrin B displayed a strong neuroprotective effect by significantly 
reducing the increase of intracellular calcium concentration in rat cortical neurons stimulated with 
glutamic acid or quisqualic acid [88]. A  crude extract from a small-scale culture of the fungus 
Acremonium  sp.  021172C cultured from an Axinella  sp. collected from Milne Bay (Papua New 
Guinea) displayed potent cytotoxicity in a primary screening using leukemia and solid tumor murine 
and human cancer cell lines. This prompted the growth of a larger-scale culture of the fungus to 
facilitate the purification of potential therapeutic metabolites which resulted in four new related linear 
octapeptides, RHM1, 2, 3 and 4, and the known peptaibiotic efrapeptins E, F, G, new efrapeptins Eα 
and H, known cyclic N-methylated scytalidamides A and B. Efrapeptins displayed antibacterial 
activity and potent cytotoxicity against murine and human cancer cell lines. RHM1 and RHM2 showed 
only weak cytotoxicity against murine cancer cell lines but RHM1 exhibited antibacterial activity 
[89,90]. These studies further confirm the potentiality of fungal metabolites from marine environment. Mar. Drugs 2010, 8                 
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2.1.6.2. Family: Halichondriidae 
The halichondrids form the most important members of demosponges. They are of particular 
interest because the composition of secondary metabolites is influenced by the presence of prokaryotic 
symbionts [91]. Sponges of the genus Halichondria such as Halichondria okadai and Halichondria 
melanodocia provide good examples for the importance of microalgal association in the production of 
natural compounds recovered from these invertebrates. Both species of Halichondria contain the 
protein phosphatase inhibitor okadaic acid [14]. It was first isolated from the sponge Halichondria 
okadai, but, later it was found out that a dinoflagellate Prorocentrum lima produced the inhibitor [17]. 
Two unidentified bacteria of the genera Pseudomonas and Alteromonas have been isolated from 
Halichondria Okadai homogenates. The Pseudomonas sp. KK10206C produced a novel   
C50-carotenoid, okadaxanthine. It turned out to be a potent singlet oxygen quencher and a well known 
source of okadaic acid [61,92,93]. Alteromonas sp. was responsible for the production of a well-known 
lactam alteramide A. The genus Alteromonas was found commonly associated with marine sponges 
that produce macrolactam and amide ester compounds with cytotoxic and antimicrobial properties. 
The tetracyclic alkaloid alteramide A exhibited cytotoxic activity against leukemia P-388, lymphoma 
L-1210 and epidermal carcinoma KB cells [93–95]. A fungal strain, Trichoderma harzianum OUPS-
N115, isolated from the Japanese specimen of Halichondria okadai yielded novel cytotoxic 
compounds such as trichodenone A, B and C. They exhibited significant cytotoxicity against leukemia 
P388 cell line [79,96,97]. A Gram- bacterial strain Rubritalea squalenifasciens HOact23
T obtained 
from Halichondria okadai yielded potent red pigmented antioxidants acyl glycol-carotenoic acids such 
as diapolycopenedioic acid xylosyl esters A, B and C [30,48,98].  Another  Halichondria  species, 
Halichondria panacea, which occurs abundantly in the Adriatic Sea, North Sea and Baltic Sea, was 
colonized by bacteria in its mesohyl compartment. Moreover, different specimens of Halichondria 
panacea collected from all the three seas harboured bacteria of same genera and indicated the 
dominance of the genus Rhodobacter, suggesting the symbiotic relationship of these bacteria with the 
sponge. Evidence has been presented to support that growth of bacteria in Halichondria panacea is 
maintained by a lectin produced from eukaryotic host. The organic extracts prepared from the sponge 
samples displayed cytotoxicity against leukemia cells, which supports the possibility of toxic bacteria 
in the sponges [99]. Bacteria synthesizing neuroactive compounds were also isolated from 
Halichondria panacea. Two such bacterial species were identified from this sponge which displayed 
the highest identity to Antarcticum vesiculatum and Psychroserpens burtonensis [100]. An 
actinobacterium Microbacterium sp. isolated from the sponge Halichondria panacea (Adriatic coast, 
Croatia) produced four glycoglycerolipids and one diphosphatidylglycerol when grown on marine 
broth and artificial sea water. The glycoglycerolipid, 2 (1-O-acyl-3-[R-glucopyranosyl-(1-3)-(6-O-
acyl-R-mannopyranosyl)]glycerol), showed positive results for antitumor activities in the initial studies 
[101]. Novel cytotoxic compounds, designated as gymnastatins A-H, Q and R, cytotoxic ergastanoids 
such as gymnasterone A, B, C and D, novel class of steroid dankasterones A and B, and dankastatins A 
and B were isolated from an ascomycete fungal strain Gymnascella dankaliensis OUPS-N134, derived 
from the sponge Halichondria japonica. Gymnastatins A, B, C, F, G, Q and R, dankastatins A and B 
exhibited potent cytotoxicity and growth inhibition in a P388 lymphocytic leukemia test system in cell 
culture. Gymnastatin Q was equally active against breast and human cancer cell lines [78,102–107]. Mar. Drugs 2010, 8                 
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Gymnasterones B, C and D, and dankasterone A showed significant cytotoxic activity in P388 
lymphocytic leukemia test system in cell culture. Dankasterone A was also active against human 
cancer cell lines [79,104,108,109]. Again from Halichondria Japonica, a fungal strain Phoma sp. 
Q60596 was obtained, which gave rise to the new antifungal antibiotic, YM-202204. It exhibited 
potent antifungal activities against Candida albicans,  Cryptococcus neoformans and Aspergillus 
fumigatus [110]. Novel antibiotics, YM-266183 and YM-266184, were found in the culture broth of 
Bacillus cereus QN03323, which was isolated from Halichondria japonica. They exhibited potent 
antibacterial activities against staphylococci and enterococci including multiple drug resistant strains, 
whereas they were inactive against Gram- bacteria [111–113]. The antifungal  macrolid 
halichondramide from another Halichondria sp. showed resemblance to the compound scytophycin B, 
which was extracted earlier from the  cyanobacterium  Scytonema pseudohofmanni, and therefore 
halichondramide is speculated to be of microbial origin [114]. Halichondramide also showed in vitro 
antimalarial activity [115]. The marine bacterial strain Bacillus pumilus AAS3 isolated from the 
Mediterranean sponge Acanthella acuta, produced a diglucosyl-glycerolipid, GGL11. Lipase catalyzed 
modification of this native substance led to the deacylated parent compound GG11. Antitumor 
promoting studies showed that the diglucosyl-glycerol GG11 strongly inhibited the growth of the 
tumor cell lines HM02 and Hep G2. Thus, it indicates the potential inhibitory activity of the compound 
with carbohydrate/glycerol backbone [116]. Twenty nine marine bacterial strains were isolated from 
the sponge Hymeniacidon perlevis at Nanji Island (China Sea), and the antimicrobial screening showed 
that eight strains inhibited the growth of terrestrial microorganisms. Among them, the strain NJ6-3-1 
with wide antimicrobial spectrum was identified as Pseudoalteromonas piscida based on its 16S rRNA 
sequence analysis. The major antimicrobial metabolite isolated from this bacterium was norhman 
[43,117]. Another specimen of Hymeniacidon perlevis from the intertidal zone of Fujiazhuang 
coastline  (China) was identified to be a good source of large amount of culturable and active 
epi/endophytic fungal strains. Of the various fungal isolates obtained from Hymeniacidon perlevis, the 
extracts of epiphytic fungus Fusarium oxysporum DLFP2008005 exhibited effective antibacterial and 
antifungal activities against Gram+ Staphylococcus epidermidis,  Bacillus subtilis, Gram- 
Pseudomonas fluorescens,  Pseudomonas aeruginosa and the yeast Candida albicans. Several 
terrestrial as well as marine Fusarium species have been reported to produce structurally diversified 
antimicrobial compounds. The potential of fungi of the genus Fusarium as producers of novel 
antibiotics is therefore quite evident [44]. 
2.1.7. Order: Haplosclerida 
2.1.7.1. Family: Callyspongiidae 
An antimicrobial fungal metabolite known as acetyl Sumiki’s acid was isolated from a seawater-
based fermentation of the fungal isolate Cladosporium herbarum, obtained from the marine sponge 
Callyspongia aerizusa in Indonesia.  Both Sumiki’s acid and its acetyl derivative showed activity 
against  Bacillus subtilis and  Staphylococcus  aureus  at 5 μg/disc [118]. The tropical sponge 
Callyspongia vaginalis from the Caribbean Sea, yielded a new tyrosine kinase inhibitor and the 
antimicrobial compound ulocladol together with the antifungal agent 1-hydroxy-6-methyl-8-(hydroxyl-Mar. Drugs 2010, 8                 
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methyl)xanthone. These compounds have been extracted from the culture of sponge-derived fungi 
Ulocladium botrylis 193A4 [119,120].  
2.1.7.2. Family: Chalinidae 
The marine sponge genus Haliclona has been extensively examined, and at least 190 metabolites 
exhibiting anti-fouling, antimicrobial, antifungal, antimalarial and cytotoxic activities have been 
isolated [121]. A fungal strain isolated from the sponge Haliclona valliculata collected from Elba, 
Italy and identified as Emericella variecolor showed a remarkable diversity of secondary metabolites. 
However, strains of the fungus Emericella variecolor have been the source of a variety of natural 
products. The culture of Emericella variecolor isolated from Haliclona valliculata proved to be 
chemically prolific. Among various compounds isolated, the novel anthraquinone, evariquinone 
revealed a strong antiproliferative activity against KB (ATCC CCL17, human cervix carcinoma) and 
NCI-H460 (NCI 503473, non-small cell lung cancer) cells [122]. Associated with Haliclona simulans 
from the west coast of Ireland, 52 bacteria isolated belonged to the genera Pseudoalteromonas, 
Pseudomonas,  Halomonas,  Psychrobacter,  Marinobacter,  Sulfitobacter,  Pseudovibrio, 
Salegentibacter, Bacillus, Cytophaga, Rhodococcus and Streptomyces [23]. These strains were found 
to be rich sources of biological activities with over 50% exhibiting antimicrobial activities. Twelve 
Streptomyces and one Bacillus strain were found to produce substance active against drug-resistant 
pathogenic bacteria. PKS (polyketide synthase) and NRPS (nonribosomal peptide synthetase) genes 
found in Actinobacteria, Bacillus,  Sulfitobacter and Pseudovibrio, suggest a high potential for 
secondary metabolite production by these organisms. Detection of wide spectrum antibiotic activities 
from  Streptomyces isolates SM2 and SM4 is another evidence to support that culturable sponge 
microbiota is an important source of biologically active compounds. The saltwater culture of an 
unidentified fungus obtained from the sponge Haliclona  sp. was found to produce several new 
hirsutane sesquiterpenes such as hirsutanols A–C and ent-gloeosteretriol. Hirsutanols are 
biosynthetically related to several compounds reported from the terrestrial fungus Coriolus consors. 
Hirsutanol A and ent-gloeosteretriol exhibited mild antibiotic activity against Bacillus subtilis [123]. 
Potent bacterial strains from Haliclona sp. (Bandangan water, North Java Sea, Indonesia) exhibiting 
antibacterial activity against the pathogenic bacteria such as Vibrio  parahaemolyticus,  Aeromonas 
hydrophila and Staphylococcus aureus were identified using rep-PCR followed by the construction of 
dendrogram and subsequent DNA sequencing. The active strains showed closest similarity to Vibrio 
parahaemolyticus,  Pseudovibrio denitrificans,  Pseudoalteromonas  sp.,  α- Proteobacterium and 
uncultured bacterium clone [2]. 
2.1.7.3. Family: Niphatidae 
The fungus Curvularia lunata isolated from the marine sponge Niphates olemda from Indonesia 
yielded two antibacterial anthraquinones such as lunatin and cytoskyrin A. Both of them were found to 
be active against Staphylococcus aureus, Escherichia coli and Bacillus subtilis [124,125]. Mar. Drugs 2010, 8                 
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2.1.7.4. Family: Petrosiidae 
Genus  Petrosia has been recognized as a source of diverse metabolites [126,127]. Petrosia 
ficiformis is a common Mediterranean sponge living in hard substrata between 5 and 45 m depth. Its 
colour mainly due to symbiotic cyanobacteria, ranges from violet to brown according to the 
illumination of environment. Petrosia ficiformis hosts a variety of heterotrophic bacteria, most of 
which live together with cyanobacteria within specialized cells called bacteriocytes [128]. 
Antimicrobial activity in several epibiotic bacterial isolates from Petrosia ficiformis has been observed 
by Chelossi et al. [129]. Two of these were identified as Rhodococcus sp. and Pseudomonas sp. by 
partial 16S rRNA gene sequencing. A strain of Penicillium brevicompactum derived from the 
specimen of Petrosia ficiformis provided two new cyclopentadepsipeptides, petrosifungins A and B 
along with the known fungal metabolites brevianamide A, mycophenolic acid (a well known 
immunosuppressive agent) and asperphenamate. Since cyclodepsipeptides constitute new class of 
potential drugs, petrosifungins A and B, may serve as lead compounds for more pharmacologically 
potent and toxicologically safe derivatives [130,131]. A strain of Aspergillus insuetus obtained from 
the surface of Petrosia ficiformis yielded two new compounds, terretonins E and F. They are potent 
inhibitors of mammalian mitochondrial respiratory chain [132]. One of the most potent antibacterial 
activities was detected in the crude extracts of a bacterial strain Micrococcus luteus R-1588-10, 
isolated from the surface of the sponge Xestospongia sp. collected from off Noumea (New Caledonia, 
southwest Pacific). Micrococcus luteus is an ubiquitous Gram+ bacteria. Two antimicrobial 
compounds such as 2,4,4’-trichloro-2’-hydroxydiphenylether (triclosan) and acyl-1-(acyl-6’-
mannobiosyl)-3-glycerol (lutoside) have been isolated from Micrococcus luteus [133]. Fungal isolates 
of  Penicillium cf. montanense obtained from the sponge Xestospongia exigua from Bali Sea 
(Indonesia) has yielded three novel decalactone metabolites, xestodecalactones A, B, and C [134]. 
Among these, xestodecalactone B showed antifungal activity against Candida albicans [79]. An 
antibacterial compound, aspergillitine was also isolated from Xestospongia exigua in association with 
the fungus Aspergillus versicolor. It showed moderate antibacterial activity against Bacillus subtilis 
[124,135]. An anti-infective alkaloid manzamine A was successfully obtained from the culture of the 
actinobacterium  Micromonospora  sp. harbouring the deep water Indonesian sponge 
Acanthostrongylophora sp. [82]. Manzamine alkaloids were reported earlier from several unrelated 
and geographically separated sponges, which suggest the microbial origin for the biosynthesis of these 
compounds [13,136]. Manzamine A was initially described as an antitumor agent against mouse 
leukemia cells [137] and recently shown to possess antimalarial properties that inhibit in vivo the 
growth of the rodent malarial parasite Plasmodium berghei [138]. Large scale culture of the sponge 
derived  Micromonospora  sp. has since been achieved in 20-litre fermentations,  maintaining the 
manzamine production [13]. The fungus Aspergillus versicolor, isolated from Petrosia sp. (Jeju Island, 
Korea) yielded three known polyketides such as decumbenones A, B and versiol, and the cytotoxic 
lipopeptide fellutamide C. The same polyketides have been also reported from soil associated fungus 
Penicillium decumbens. Decumbenone A is a good inhibitor of melanin [139–141].  Mar. Drugs 2010, 8                 
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2.1.8. Order: Lithistida 
2.1.8.1. Family: Neopeltidae 
Lithistid sponges are renowned among marine organisms for their ability to produce a diverse array 
of biologically active metabolites [142], including novel peptides characterized by a high proportion of 
D and/or N-methylated amino acids. The similarity between lithistid peptides and those from 
microorganisms leads to the speculation that lithistid peptides might arise from symbiotic microbes 
[143]. A Gram- strain, 1537–E7 was identified as new Pseudomonas species from the surface of the 
sponge Homophymia  sp. collected from off Touho (New Caledonia). Among the five compounds 
isolated from this bacterium, compound 1 (2-undecyl-4-quinolone) was active against the malarial 
parasite Plasmodium falciparum and HIV-1. Compound 2 (2-undecen-1’-yl-4-quinolone) displayed 
mild toxicity and compound 4 (2-nonyl-4-hydroxyquinoline N-oxide) showed antimicrobial activity 
against Staphylococcus aureus as well as cytotoxicity [142].  
2.1.8.2. Family: Theonellidae 
The marine sponge Theonella swinhoei from Palau contains a cytotoxic polyketide, swinholide A 
and the bicyclic glycopeptide antifungal compound theopalauamide [144]. Bacteria associated with 
this sponge include unicellular cyanobacteria, unicellular bacteria and filamentous bacteria. 
Swinholide A is likely to be a bacterial metabolite because this compound was associated with 
fractions from unicellular bacteria in Theonella swinhoei [145]. A single morphotype of a filamentous 
bacterium was present in a separate fraction that contained the antifungal compound theopalauamide 
[146]. Subsequent application of molecular approaches identified this filamentous bacterium as novel 
δ-Proteobacterium related to myxobacteria. According to 16S rDNA data, the filamentous strain is a 
previously unknown  -Proteobacterium with close association to the myxococcales and designated as 
‘Candidatus Entotheonella palauensis’ [26]. An antifungal glycopeptide known as theonegramide was 
previously isolated from Theonella swinhoei, collected from Philippines at a depth of 20 m [147]. 
Interestingly, 16S sequences which showed 98% identity to that of the filamentous δ-Proteobacterium, 
Entotheonella palauensis were detected in Theonella swinhoei specimens containing the closely 
related metabolites theonegramide (from the Philippines) and theonellamide F (from Japan), while 
they were absent in sponges with different metabolites [148]. Theopalauamide-type compounds 
therefore, seem to be chemical markers for symbiosis of Entotheonella palauensis in sponges [145]. 
Discovery of onn genes encoding the biosynthesis of onnamide A in the microbial metagenome of the 
sponge Theonella swinhoei was made by Piel et al. [149]. This polyketide exhibited extremely potent 
antitumor activities. This provides the first experimental proof for bacterial origin of marine sponge 
derived natural compounds [150]. Mar. Drugs 2010, 8                 
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2.1.9. Order: Poecilosclerida 
2.1.9.1. Family: Acarnidae 
Three novel cytotoxic polyketides, brocaenols A-C were produced by Penicillium brocae obtained 
from a tissue sample of the Fijian sponge Zyzzya sp. When tested against HCT-116 cell line, all three 
compounds showed cytotoxicity [151,152]. 
2.1.9.2. Family: Isodictyidae 
An antibacterial compound known as cyclo-(L-proline-L-methionine) has been isolated from the 
culture broth of a symbiotic bacterium Pseudomonas aeruginosa, obtained from the Antarctic sponge 
Isodictya setifera. It showed antimicrobial activity against Bacillus subtilis, Staphylococcus aureus, 
and Micrococcus luteus [153].  
2.1.9.3. Family: Raspailiidae 
A fungal strain Coniothyrium sp. 193477, isolated from the sponge Ectyoplasia ferox from the 
waters around the Caribbean Islands of Dominica, yielded novel antimicrobial compounds such as 
(3S)-(3´,5´-dihydroxyphenyl)butan-2-one and 2-(1´(E)-propenyl)-octa-4(E),6(Z)-diene-1,2-diol 
together with known fungal metabolites such as (3R)-6-methoxymellein, (3R)-6-methoxy-7-
chloromellein and cryptosporiopsinol. Among these, cryptosporiopsinol demonstrated significant 
antimicrobial activity [154]. Potent cytotoxic compounds, epoxyphomalin A and B were discovered 
from Phoma sp., associated with Ectyoplasia ferox collected from the same region. The former one 
showed superior activity against various human tumor cell lines [155]. Another fungus Spicellum 
roseum 193H15, derived from Ectyoplasia ferox was found to produce trichothecenes such as 
trichodermol and 8-deoxytrichothecin. They considerably inhibited the activity of LacCer synthase 
(role in oncogene expression and cell proliferation) in neuroblastoma cells [156,157]. The fungus also 
yielded two cyclohexadepsipeptides, spicellamides A and B [48,158]. 
2.1.9.4. Family: Mycalidae 
An actinobacterium strain Saccharopolyspora sp. nov. associated with the sponge Mycale plumose 
from Qingdao coast (China) showed cytotoxic activities against temperature sensitive mutant cell lines 
of mouse (tsFT210). This led to the isolation of two prodigiosins analogs- metacycloprodigiosin and 
undecylprodigiosin. Prodigiosins are a family of naturally occurring polypyrrole red pigments 
produced by a restricted group of microorganisms including Streptomyces and Serratia strains. They 
are known to exhibit a wide range of biological activities. Both the above mentioned prodigiosin 
analogs exhibited potent in vitro cytotoxic activity against cancer cell lines such as P388, HL60,  
A-549, BEL-7402 and SPCA4 [159]. The fungus Penicillium auratiogriseum was also isolated from 
the specimen of Mycale plumose taken from the same geographical area. A new cytotoxic compound 
(S)-2,4-dihydroxy-1-butyl-(4-hydroxy) benzoate and a known compound fructigenine A were obtained 
from the fungus. Both the compounds were tested for their antitumor activity and exhibited potent 
cytotoxic effects [160]. Besides these, two new quinazoline alkaloids such as aurantiomides B and C Mar. Drugs 2010, 8                 
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showing moderate cytotoxic activities were isolated from another strain of Penicillium auratiogriseum 
associated with Mycale plumose from China [161]. Exophilin A, a new antibacterial compound, was 
discovered in the culture of the fungus Exophiala pisciphila NI10102, that was isolated from a marine 
sponge  Mycale adhaerens. Exophilin A showed antimicrobial activity against Gram+   
bacteria [48,162]. 
2.1.9.5. Family: Myxillidae 
A new antimicrobial fungal metabolite known as microsphaeropsisin together with the known 
compounds (R)-mellein, (3R,4S)-hydroxymellein, (3R,4R)-hydroxymellein and 4,8-dihydroxy-3,4-
dihydro-2H-naphthalen-1-one were obtained from the fungal strain Microsphaeropsis  sp. H5-50 
associated with the marine sponge Myxilla incrustance, collected from Helgoland, Germany [154]. 
Microsphaeropsin, an eremophilane derivative showed antifungal activity at the 50 μg level [79]. 
2.1.10. Order: Spirophorida 
2.1.10.1. Family: Tetillidae 
A chitinase exhibiting antifungal activity was isolated from marine Streptomyces  sp. DA11 
associated with south China sponge Craniella australiensis. Compared with chitinase derived from 
terrestrial organisms, marine chitinase with higher pH and salinity tolerance may contribute to special 
biotechnological applications. Therefore, novel marine chitinase could be of great importance [163]. 
2.1.11. Order: Verongida 
2.1.11.1. Family: Aplysinellidae 
Ten strains of marine actinobacteria belonging to the genus Salinospora were isolated from the 
Great Barrier Reef sponge Suberea clavata (formerly Pseudoceratina clavata) [164]. The Salinospora 
group, a relatively newly discovered group of actinobacteria, has great applied potential. The 
Salinospora strains previously isolated from marine sediments showed significant cancer cell 
cytotoxicities as well as antifungal and antibiotic activities [165]. Significantly, Salinospora forms a 
potential new source of rifamycins and polyketide synthesis gene clusters specific to rifamycin 
synthesis. Salinospora isolate from Suberea clavata was found to produce compounds of the rifamycin 
class, including rifamycin B and rifamycin SV [166]. Other culturable symbiotic bacterial 
communities isolated from Suberea clavata include α-,  γ-Proteobacteria, Bacteriodetes and   
Firmicutes [167]. 
2.1.11.2. Family: Aplysinidae 
Sponges of the Aplysinidae family are abundant in the subtropical and tropical waters of the 
Mediterranean Sea, Pacific and Atlantic Oceans [168]. Aplysina sponges harbour large amounts of 
microorganisms with antimicrobial activities that are embedded within the mesohyl [41,168]. The 
Mediterranean sponge Aplysina aerophoba is especially rich in bacteria. The amount of bacteria 
present in the sponge tissue matrix exceeds the microbial concentration of the seawater by two to three Mar. Drugs 2010, 8                 
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orders of magnitude [169]. One of the studies conducted using FISH on Aplysina aerophoba and its 
sibling species Aplysina cavernicola showed that the bacterial profiles of both species was very 
similar. Up to 40% of the sponge biomass consisted of bacteria and cyanobacteria. A large fraction of 
the microbial community was specific to and permanently associated with the host sponge 
[41,168,169]. The similarity of the bacterial communities in Aplysina aerophoba and Aplysina 
cavernicola corresponds to similarities in the natural product profiles of both sponges which are 
characterized by brominated alkaloids with cytotoxic activities and repellent properties against 
predators [12,41]. Among the bacterial isolates obtained from these species those which showed 
antimicrobial activity were numerically the most abundant in the genus Pseudoalteromonas and the 
class α-Proteobacteria. A general pattern was observed in that Gram+ bacteria inhibited Gram+ strains 
while Gram- bacteria inhibited Gram- isolates. Antimicrobial activities were also found against clinical 
isolates,  i.e., multi-drug resistant Staphylococcus aureus and Staphylococcus  epidermidis strains 
isolated from hospital patients. The high recovery of strains with antimicrobial activity suggests that 
marine sponges represent an ecological niche which harbours largely uncharacterized microbial 
diversity and yet undiscovered metabolic potential [41]. Antimicrobial activity of bacterial isolates 
from Aplysina aerophoba collected from the Mediterranean coast of France has been tested against a 
set of standard Gram+, Gram- and eukaryotic microorganisms. The results showed that Bacillus 
subtilis strains A184, A190 and A202 exhibited strong activity against the fungus Candida albicans 
[170]. It is generally accepted that a combination of fungicidal and hemolytic activity in Bacillus is a 
valid indicator for the presence of lipopeptide from the iturin or surfactin class [171–173]. For the 
Bacillus subtilis strains A184, A190 and A202, these features are consistent. The results of MALDI 
MS which was applied to study the production of secondary metabolites by Bacillus species showed 
that strain A184 produced surfactins, iturins and fengycins while strain A190 produced surfactin and 
strain A202 produced iturin. The highly versatile strain Bacillus subtilis A184 was highly active 
against the multidrug resistant pathogenic Staphylococcus aureus and Staphylococcus epidermidis. 
Another species, Bacillus pumilus A586 demostrated high activity against Staphylococcus aureus and 
produced plumilacidin containing β-hydroxy fatty acid (surfactin like compound) [170]. An 
undescribed fungus of the genus Microsphaeropsis, isolated from the Mediterranean specimen of 
Aplysina aerophoba, was shown to produce a Protein Kinase C inhibitor known as 10-Hydroxy-18-
methoxylbetaenone [174]. Since PKC plays an important role in neoplastic transformation, 
carcinogenesis and tumour cell invasion, those agents which inhibit the action of PKC are 
therapeutically very important [175]. 
2.1.11.3. Family: Pseudoceratinidae 
Extract of Metarrhizium  sp. 001103 from Pseudoceratina purpurea (Fiji), yielded six known   
N-methylated cyclic depsipeptides of the destruxin family. They include destruxins A, B, B2, 
desmethyl B, E and E2 chlorohydrin. Destruxins A, B2, desmethyl B and E chlorohydrin displayed 
selective inhibition of human tumor cell lines. E2 chlorohydrin showed cytotoxicity towards murine 
c38 cell line. E chlorohydrin was the most potent among the group [90]. 
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2.2. Class: Calcarea 
Order: Clathrinida 
Family: Leucettidae 
Nonribosomal cyclic peptide leucamide A was isolated from the sponge Leucetta microraphis, 
obtained from the Great Barrier Reef of Australia. The compound was found to inhibit the growth of 
three tumor cell lines (stomach carcinoma, liver carcinoma and liver carcinoma with mutated p53). 
Leucamide A closely resembles the compound albeit, which is found frequently in cyanobacteria. 
Scanning electromicrographs of Leucetta microraphis revealed the presence of microbial symbionts, 
including cyanobacteria in the tissue. The sponge-derived leucamide A might, therefore be produced 
by cyanobacteria associated with it and not by the invertebrate itself [120]. 
2.3. Unidentified sponges  
A marine-derived strain of the fungus Emericella variecolor, obtained from a Venezuelan sponge, 
yielded new compounds along with a group of known metabolites. Some of the novel compounds such 
as varitriol and varixanthone exhibited potent pharmaceutical activities. Varitriol displayed increased 
potency towards selected renal, CNS and breast cancer cell lines, whereas varixanthone showed 
antimicrobial activity [176]. Two novel antimycin antibiotics viz. urauchimycins A and B, were 
isolated from a fermentation broth of Streptomyces  sp. Ni-80. The strain was isolated from an 
unidentified sponge. They are the first antimycin antibiotics which possess a branched side chain 
moiety. They exhibited inhibitory activity against morphological differentiation of Candida albicans 
[177]. A strain of the fungus Microascus longirostris SF-73 from a marine sponge collected at 
Harrington Point (Otago Harbour, New Zealand) was found to produce secondary metabolites such as 
cathestatin A, B and C, which strongly inhibited cystein proteases. Since specific and selective 
protease inhibitors are potentially powerful tools in clinical therapy, these inhibitors could be used in 
inactivating the target proteases in the pathogenic processes of human diseases such as emphysema, 
arthritis, pancreatitis, thrombosis, high blood pressure, muscular dystrophy, cancers, AIDS and many 
others [178]. Three antibacterial compounds were isolated from the fungus Aspergillus ostianus 
01F313, derived from an unidentified sponge collected at Pohnpei (The federated state of Micronesia). 
They include 8-chloro-9-hydroxy-8,9-deoxyasperlactone, 9-chloro-8-hydroxy-8,9-deoxyasperlactone 
and 9-chloro-8-hydroxy-8,9-deoxyaspyrone [179]. From the same strain, five cytotoxic compounds 
such as aspinorene, dihydroaspyrone, aspergillides A, B and C were also obtained when cultured in a 
brominated medium. They exhibited cytotoxicity against lymphocytic leukemia cells (L1210) 
[48,180,181]. Cultivation of the fungus Cryptosphaeria eunomia, obtained from an unidentified 
sponge at Pohnpei yielded the antimycobacterial compounds diaporthein A and B. These compounds 
have been previously isolated from the terrestrial fungus Diaporthe sp. BCC 6140 [48,182,183]. 
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Table 2. Clinically important bioactive compounds from sponge-microbe associations. 
Class: Demospongiae   
Order 
Astrophorida 
Family  
Ancorinidae 
 
Sponge Symbiont  Compound  Property  Reference 
Stelletta tenuis (South China 
Sea)  
Alcaligenes faecalis A72 
(β-Proteobacteria) 
Cyclo-(L-Pro-L-Phe) Antimicrobial  [42] 
Jaspis aff. johnstoni (Indo-
Pacific)  
Hyphomycete fungus 
(Deuteromycota (fungus)) 
Chloriolin B  Antitumor  [43–45] 
Order 
Chondrosida 
Family 
Chondrillidae 
Chondrosia reniformis  
(Elba, Italy) 
Penicillium rugulosum 
(Ascomycota (fungus)) 
Prugosene A1  Anti-infective  [46–48] 
   Prugosene A2  Anti-infective  [46–48] 
   Prugosene A3  Anti-infective  [46–48] 
   Prugosene B1  Anti-infective  [46–48] 
   Prugosene B2  Anti-infective  [46–48] 
   Prugosene C1  Anti-infective  [46–48] 
   Prugosene C2  Anti-infective  [46–48] 
Order 
Dendroceratida 
Family 
Darwinellidae 
Dendrilla nigra (Vizhinjam, 
India)  
Streptomyces dendra sp. 
nov.MSI051 
(Actinobacteria) 
Unidentified 
compound 
Antibacterial [51] 
 Dendrilla nigra 
(Kanyakumari, India)  
Streptomyces sp. BLT7 
(Actinobacteria) 
Unidentified 
compound 
Antibacterial [52,53] 
 Dendrilla nigra (South east 
coast, India)  
Nocardiopsis dassonvillei 
MAD08 (Actinobacteria) 
Acetic acid,-butyl- 
ester 
Antimicrobial [53] 
     Ethanol, 2-
(octyloxy)- 
Antimicrobial   [53] 
   Oxalic  acid,  allyl- 
nonyl ester 
Antimicrobial   [54] 
     2-Isopropyl-5-
methyl-1-heptanol 
Antimicrobial   [53] 
     Butylated-
hydroxytoluene 
Antimicrobial   [53] 
   Cyclohexane-
carboxylic acid, 
hexyl ester 
Antimicrobial [53] 
   Diethyl-  phthalate  Antimicrobial  [53] 
   Pentadecanal-  Antimicrobial    [53] 
     1-Tridecanol  Antimicrobial    [53] 
     9-Octadecenal  Antimicrobial    [53] 
     Hexadecanoic acid, 
methyl- ester 
Antioxidant, hypo-
cholesterolemic, 
nematicide, 
antiandrogenic, hemolytic 
[53] 
    n-Hexadecanoic- acid  Antioxidant, hypo-
cholesterolemic, 
nematicide, 
antiandrogenic, hemolytic 
[53] Mar. Drugs 2010, 8                 
 
1437
Table 2. Cont. 
     Hexadecanoic-  acid, 
ethyl ester 
Antioxidant, hypo-
cholesterolemic, 
nematicide, 
antiandrogenic, hemolytic 
[53] 
   9-Octadecenoic- 
acid-  
(Z)-, methyl- ester 
Anti-inflammatory, 
antiandrogenic, cancer- 
preventive, dermatitigenic, 
hypo-cholesterolemic, 
anemiagenic 
[53] 
   Oleic  Acid  Anti-inflammatory, 
antiandrogenic, cancer- 
preventive, dermatitigenic, 
hypo-cholesterolemic, 
anemiagenic 
[53] 
   (E)-9-Octadecenoic-
acid ethyl ester 
Anti-inflammatory, 
antiandrogenic, cancer- 
preventive, dermatitigenic, 
hypo-cholesterolemic, 
anemiagenic 
[53] 
   9-Octa-decenamide- 
(Z)-  
Anti-inflammatory, 
antiandrogenic, cancer- 
preventive, dermatitigenic, 
hypo-cholesterolemic, 
anemiagenic 
[53] 
Order 
Dictyoceratida 
Family 
Dysideidae 
Lamellodysidea herbacea 
(Great Barrier Reef, Australia)  
Oscillatoria spongeliae 
(Cyanobacteria) 
Dihydrodysamide C  Therapeutic 
(unknown action) 
[57] 
   Didechloro-
dihydrodysamide C 
Therapeutic 
(unknown action) 
[57] 
Dysidea sp. (Eastern Samoa)    Vibrio sp. (γ-
Proteobacteria) 
Tetrabromo-diphenyl 
ethers 
Cytotoxic, antibacterial  [59] 
Lamellodysidea herbacea  
(Republic of Palau)  
 Oscillatoria spongeliae 
 (Cyanobacteria) 
2-(2',4'-dibromo-
phenyl)-4,6-
dibromophenol 
Anibacterial [40] 
Dysidea avara 
(Adriatic Sea)  
Unidentified bacterium 2-methylthio-1,4-
naphthoquinone 
Antiangiogenic, 
antimicrobial 
[61,62] 
Irciniidae  Ircinia fasciculata 
(Mediterranean Sea)  
Penicillium 
chrysogenum  
(Ascomycota (fungus)) 
Sorbicillactone A  Antileukemic, anti HIV  [64,65] 
Spongiidae  Hyatella sp.   Vibrio sp. M22-1 
(γ- Proteobacteria) 
Andrimid  Antibiotic [66] 
  Spongia sp. (Hawaii) 
 
Myrothecium verrucaria 
973023 
(Deuteromycota 
(fungus)) 
3-hydroxyroridin E  Antileukemic, 
antitumor 
[69] 
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     13'-acetyl-trichoverrin  B  Antileukemic, 
antitumor 
[69] 
   Roridin  A  Antileukemic, 
antitumor  
[69] 
   Roridin  L  Antileukemic, 
Antitumor 
[69] 
   Roridin  M  Antileukemic, 
Antitumor 
[69] 
   Verrucarin  M  Antileukemic, 
antitumor  
[69] 
   Verrucarin  A  Antileukemic, 
antitumor  
[69] 
   Isororidin  A  Antileukemic, 
antitumor  
[69] 
   Epiroridin  E  Antileukemic, 
antitumor  
[69] 
   Trichoverrin  A  Antileukemic, 
antitumor  
[69] 
   Trichoverrin  B  Antileukemic, 
antitumor  
[69] 
Thorectidae  Hyrtios altum  
(Okinawa)  
Vibrio sp.  
(γ-Proteobacteria) 
Trisindoline Antibiotic  [70–72] 
Hyrtios sp. 
(Caribbean Sea)  
 Aspergillus niger  
(Ascomycota (fungus)) 
Asperazine Antileukemic, 
cytotoxic 
[45,74,75] 
Hyrtios proteus 
(Dry Tortugas National Park, 
Florida ) 
Aspergillus niger  
(Ascomycota (fungus)) 
Asperazine Antileukemic, 
cytotoxic 
[76] 
   Malformin  C  Antitumor  [76] 
Fascaplysinopsis reticulate 
(Great Barrier Reef, Australia) 
Pseudo- 
alteromonas 
maricaloris  
KMM 636T 
(γ-Proteobacteria) 
Bromo-alterochromide A  Cytotoxic  [48,76] 
 Bromo-alterochromide  A  Cytotoxic  [48,76] 
Order 
Hadromerida 
Family 
Spirastrellidae 
Spirastrella vagabunda 
(Indonesia)  
Unidentified fungus  14,15-secocurvularin Antibiotic  [77,78] 
Suberitidae 
  
Suberites domuncula 
(Northern Adriatic Sea)  
α-Proteobacterium 
MBIC3368 (isolate 1) 
Unidentified compound  Antiangiogenic, 
antimicrobial, 
hemolytic, cytotoxic 
[15,79] 
  α-Proteobacterium 
MBIC3368 (isolate 2) 
Unidentified compound  Antimicrobial, 
hemolytic 
[15,80] 
  Idiomarina sp.  
(γ-Proteobacteria) 
Unidentified compound  Hemolytic  [15,80] Mar. Drugs 2010, 8                 
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   Pseudomonas sp. (isolate 1) 
(γ-Proteobacteria) 
Unidentified compound  Hemolytic, cytotoxic  [15,80] 
  Pseudomonas sp. (isolate 2) 
(γ-Proteobacteria) 
Unidentified compound  Antiangiogenic, 
antimicrobial, 
hemolytic, cytotoxic 
[15,80] 
Order 
Halichondrida 
Family 
Axinellidae 
Ptilocaulis trachys 
(Enewetak Atoll, Marshall 
Island, Pacific Ocean)  
Lyngbya majuscula  
(Cyanobacteria) 
Majusculamide C  Antifungal  [81,82] 
Axinella sp. 
(South China Sea)  
 
Myrothecium sp. JS9 
(Deuteromycota (fungus)) 
Roridin A  Antifungal  [83] 
   Roridin  D  Antifungal  [83] 
Axinella sp. 
(Papaua New Guinea)  
 Penicillium citrinum 
(Ascomycota (fungus)) 
Isocyclocitrinol A 
 
Antibacterial   [84] 
   22-acetyl-
isocyclocitrinol A 
Antibacterial [84] 
Axinella verrucosa  
(Mediterranean Sea)  
 Penicillium sp. 
(Ascomycota (fungus)) 
Oxaline Anti-proliferative [85] 
   Griseofulvin  Antifungal [85,86] 
   Communesin  B  Antileukemic  [85,87] 
   Communesin  C  Antileukemic  [85,87] 
   Communesin  D  Antileukemic  [85,87] 
Axinella sp. 
(Papua New Guinea)  
Acremonium sp. 
(Ascomycota (fungus)) 
Efrapeptin E  Cytotoxic, 
antibacterial 
[90] 
   Efrapeptin  F  Cytotoxic, 
antibacterial 
[90] 
   Efrapeptin  Eα Cytotoxic, 
antibacterial 
[90] 
   Efrapeptin  G  Cytotoxic, 
antibacterial 
[89] 
   Efrapeptin  H  Cytotoxic, 
antibacterial 
[90] 
   RHM1  Antibacterial  [89] 
Axinella damicornis 
(Mediterranean Sea)  
 Aspergillus niger  
(Ascomycota (fungus)) 
Bicoumanigrin Anticancer,  cytotoxic  [88] 
   Aspernigrin  B  Neuroprotective  [88] 
Halichondriidae  Halichondria okadai  
 
Alteromonas sp. 
(γ-Proteobacteria) 
Alteramide A  Anticancer, cytotoxic  [93–95] 
Halichondria okadai (Japan)   Trichoderma harzianum 
OUPS-N115 (Ascomycota 
(fungus)) 
Trichodenone A  Antileukemic, 
cytotoxic 
[78,96,97] 
     Trichodenone B  Antileukemic, 
cytotoxic 
[78,96,97] 
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     Trichodenone  C  Antileukemic, 
cytotoxic 
[78,96,97] 
Halichondria okadai  Rubritalea  squalenifasciens 
HOact23
T 
(Verrucomicrobiae) 
Dia-polycopenedioic acid 
xylosyl esters A 
 
Antioxidant [30,48,98] 
   Dia-polycopenedioic  acid 
xylosyl esters B 
Antioxidant [30,48,98] 
   Dia-polycopenedioic  acid 
xylosyl esters C 
Antioxidant [30,48,98] 
Halichondria 
panacea  
Unidentified bacterium  Unidentified compound  Neuroactive  [100] 
Halichondria 
panacea 
(Adriatic coast, 
Croatia)  
Microbacterium sp. 
(Actinobacteria) 
1-O-acyl- 
3-[R-glucopyranosyl-(1-3)-
(6-O-acyl-R-manno-
pyranosyl)]-glycerol 
Antitumor [101] 
Halichondria 
japonica (Osaka Bay, 
Japan)  
Gymnascella dankaliensis 
OUPS-N134  
(Ascomycota (fungus)) 
Gymnostatin A  Antileukemic, 
cytotoxic 
[78,102,103,105] 
   Gymnostatin  B  Antileukemic, 
cytotoxic 
[78,102,103,105] 
   Gymnostatin  C  Antileukemic, 
cytotoxic 
[78,102,103,105] 
   Gymnostatin  F  Antileukemic, 
cytotoxic 
[106] 
   Gymnostatin  G  Antileukemic, 
cytotoxic 
[106] 
   Gymnostatin  Q  Antileukemic,  anti 
cancer, cytotoxic  
[107] 
   Gymnostatin  R  Antileukemic, 
cytotoxic 
[107] 
   Gymnasterone  A  Cytotoxic  [108,109] 
   Gymnasterone  B  Antileukemic, 
cytotoxic 
[108,109] 
   Gymnasterone  C  Antileukemic, 
cytotoxic 
[108] 
   Gymnasterone  D  Antileukemic, 
cytotoxic 
[108] 
   Dankastatin  A  Antileukemic, 
cytotoxic 
[107] 
   Dankastatin  B  Antileukemic, 
cytotoxic 
[107] 
   Dankasterone  A  Antileukemic, 
anticancer, cytotoxic 
[104] 
Halichondria 
Japonica (Japan)  
Phoma sp. Q60596 
(Ascomycota (fungus)) 
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  Halichondria 
Japonica  
Bacillus cereus QN03323 
(Firmicutes) 
YM-266183 Antibacterial    [111–113] 
   YM-266184  Antibacterial  [111–113] 
Acanthella acuta 
(Mediterranean Sea)  
 Bacillus pumilus AAS3 
(Firmicutes) 
GG11 Antitumor  [116] 
Hymeniacidon 
perlevis 
(Nanji Island, China 
Sea)  
Pseudo-alteromonas piscicida 
NJ6-3-1 
(γ-Proteobacteria) 
Norharman Antimicrobial  [43,117] 
Hymeniacidon 
perlevis 
(Fujiazhuang coast, 
China)  
Fusarium oxysporum 
DLFP2008005 
(Ascomycota (fungus)) 
Unidentified compound  Antibacterial, 
antifungal 
[44] 
Order 
Haplosclerida 
Family 
Callyspongiidae 
Callyspongia 
aerizusa 
(Indonesia)  
Cladosporium herbarum  
(Deuteromycota (fungus)) 
Sumiki’s acid  Antibacterial  [118] 
    Acetyl Sumiki’s acid  Antibacterial  [118] 
Callyspongia 
vaginalis 
(Caribbean Sea)  
Ulocladium botrylis 193A4 
(Ascomycota (fungus)) 
Ulocladol Antimicrobial  [119,120] 
   1-hydroxy-6-methyl-8-
(hydroxylmethyl)- 
xanthone 
Antifungal [119,120] 
Chalinidae  Haliclona valliculata 
(Elba, Italy)  
 Emericella variecolor  
(Ascomycota (fungus)) 
Evariquinone Anti-proliferative  [122] 
Haliclona simulans 
(Ireland)  
Pseudo-alteromonas sp. PA2 ( 
γ-Proteobacteria) 
Unidentified Antimicrobial [123] 
  Pseudo-alteromonas sp. PA4 ( 
γ-Proteobacteria) 
Unidentified Antimicrobial [123] 
  Pseudo-alteromonas sp. PA5 ( 
γ-Proteobacteria) 
Unidentified Antimicrobial [123] 
  Pseudo-alteromonas sp. PA5 ( 
γ-Proteobacteria) 
Unidentified Antimicrobial [123] 
  Halomonas sp. HM4 ( γ-
Proteobacteria) 
Unidentified Antimicrobial [123] 
  Psychrobacter sp. PB1 (γ-
Proteobacteria) 
Unidentified Antimicrobial [123] 
  Marinobacter sp. MB1 (γ-
Proteobacteria) 
Unidentified Antimicrobial [123] 
  Pseudovibrio sp. PV1 (α-
Proteobacteria) 
Unidentified Antimicrobial [123] 
  Pseudovibrio sp. PV2 ( α-
Proteobacteria) 
Unidentified Antimicrobial [123] 
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   Pseudovibrio sp. PV4 ( α-
Proteobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM1 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM2 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM3 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM4 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM5 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM6 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM7 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM8 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM9 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM10 
(Actinobacteria)  
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM11 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM12 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM14 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM16 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM17 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM18 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Streptomyces sp. SM19 
(Actinobacteria) 
Unidentified Antimicrobial [123] 
  Bacillus sp. BC1 (Firmicutes)  Unidentified Antimicrobial [123] 
  Bacillus sp. BC2 (Firmicutes)  Unidentified Antimicrobial  [123] 
Haliclona sp. 
(Tomini Bay, North 
Sulawesi, Indonesia)  
Unidentified fungus  Hirsutanol A  Antibiotic   [123] 
   ent-gloeosteretriol  Antibiotic [123] Mar. Drugs 2010, 8                 
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  Haliclona sp.(North 
Java Sea, Indonesia) 
Unidentified bacterium 1  Unidentified Antibacterial  [2] 
 
  Unidentified bacterium 2  Unidentified Antibacterial  [2] 
  Unidentified bacterium 3  Unidentified Antibacterial [2] 
  Unidentified bacterium 4  Unidentified Antibacterial [2] 
  Unidentified bacterium 5  Unidentified Antibacterial [2] 
Niphatidae  Niphates olemda 
(Indonesia)  
Curvularia lunata (Ascomycota 
(fungus)) 
Lunatin Antibacterial  [124,125] 
   Cytoskyrin  A  Antibacterial  [124,125] 
Petrosiidae  Petrosia ficiformis 
(Capo S. Andrea, 
Elba, Italy)  
Penicillium  
brevicompactum (Ascomycota 
(fungus)) 
Mycophenolic acid  Immuno-suppressant  [128] 
 Aspergillus  insuetus 
(Ascomycota (fungus)) 
Terretonins E  Inhibit mammalian 
mitochondrial 
respiratory chain 
[132] 
   Terretonins F  Inhibit mammalian 
mitochondrial 
respiratory chain 
 
[132] 
Petrosia sp. (Jeju 
Island, Korea) 
Aspergillus versicolor 
(Ascomycota (fungus)) 
Decumbenone A  Melanin inhibitor  [139] 
   Fellutamide C  Cytotoxic  [140] 
Xestospongia sp. 
(Off Noumea (New 
Caledonia, southwest 
Pacific))  
Micrococcus luteus R-1588-10 
(Actinobacteria) 
2,4,4’-trichloro-2’-
hydroxy-diphenylether 
(Triclosan) 
Antimicrobial 
 
[133] 
   Acyl-1-(acyl-6’-
mannobiosyl)-3-glycerol 
(Lutoside) 
Antimicrobial [133] 
Xestospongia exigua 
(Bali Sea, Indonesia)  
Penicillium cf. montanense 
(Ascomycota (fungus)) 
Xestodecalactone B  Antifungal  [79,134] 
Xestospongia exigua 
(Indonesia)  
Aspergillus versicolor 
(Ascomycota (fungus)) 
Aspergillitine Antibacterial  [124,135] 
Acantho-
strongylophora sp. 
(Indonesia)  
Micromonospora sp. 
(Actinobacteria) 
Manzamine A  Antitumor, 
antimalarial 
[82,137, 
138] 
Order 
Lithistida 
Family 
Neopeltidae 
Homophymia sp. 
(Off Touho, New 
Caledonia)  
Pseudomonas sp. 1537-E7 (γ-
Proteobacteria) 
2-undecyl-4-quinolone Antimalarial 
Anti HIV 
[142] 
   2-undecen-1'  -yl-4-
quinolone 
Cytotoxic [142] 
   2-nonyl-4-hydroxy-
quinoline N-oxide 
Antibacterial,  
cytotoxic 
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Theonellidae  Theonella swinhoei 
(Palau)  
Unidentified bacterium  Swinholide A  Cytotoxic  [144,145] 
  Candidatus Entotheonella 
palauensis (δ-Proteobacteria) 
Theopalauamide Antifungal  [26,144,146] 
Theonella swinhoei 
(Philippines)  
Entotheonella palauenis (δ-
Proteobacteria) 
 
Theonegramide Antifungal  [145,147] 
Theonella swinhoei 
(Hachijojima Island, 
Japan)  
Uncultured bacterium  Onnamide A  Antitumor  [149,150] 
Order 
Poecilosclerida 
Family 
Acarnidae 
Zyzzya sp. (Fiji)   Penicillium brocae (Ascomycota 
(fungus)) 
Brocaenol A  Cytotoxic  [151,152] 
   Brocaenol  B  Cytotoxic  [151,152] 
    Brocaenol C  Cytotoxic  [151,152] 
Isodictyidae  Isodictya setifera 
(Hut Point and 
Danger Slopes, Ross 
Island, Antarctica)  
 Pseudomonas aeruginosa (γ-
Proteobacteria) 
Cyclo-(L-proline-L-
methionine) 
Antibacterial [153] 
Raspailiidae  Ectyoplasia ferox 
(Dominica, 
Carribean Island)  
Coniothyrium sp. 193477  
(Deuteromycota (fungus)) 
(3S)-(3´,5´-
dihydroxyphenyl) butan-2-
one 
Antimicrobial [154] 
   2-(1´(E)-propenyl)-octa-
4(E),6(Z)-diene-1,2-Diol 
Antimicrobial [154] 
   (3R) 6-methoxymellein  Antimicrobial  [154] 
   (3R)-6-methoxy-7-
chloromellein 
Antimicrobial [154] 
   Crypto-sporiopsinol  Antimicrobial  [154] 
  Phoma sp. 
(Ascomycota (fungus)) 
Epoxyphomalin A  Antitumor  [155] 
 Spicellum  roseum 193H15 
(Deuteromycota (fungus)) 
Trichodermol Anticancer  [156,157] 
   8-deoxytrichothecin Anticancer  [156,157] 
Mycalidae  Mycale plumose 
(Qingdao coast, 
China)  
Saccharopolyspora sp. nov. 
(Actinobacteria) 
 
Metacyclo-prodigiosin Anticancer  [159] 
   Undecyl-prodigiosin  Anticancer  [159] 
  Penicillium auratiogriseum 
(Ascomycota (fungus)) 
(S)-2,4-dihydroxy-1-
butyl(4-hydroxy)-benzoate 
Antitumor [160] 
   Fructigenin  A  Antitumor  [160] 
   Aurantiomide  B  Cytotoxic  [161] 
   Aurantiomide  C  Cytotoxic  [161] 
Mycale adhaerens   Exophiala pisciphila N110102 
(Ascomycota (fungus)) 
Exophilin A  Antibacterial  [48,162] Mar. Drugs 2010, 8                 
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Myxillidae  Myxilla incrustance 
(Helgoland, 
Germany)  
Microsphaeropsis sp. H5-50 
(Anamorphic fungus) 
Microsphaeropsisin Antifungal  [79,154] 
   ( R)-mellein Antimicrobial  [154] 
   (3R,4S)- hydroxymellein  Antimicrobial  [154] 
   (3R,4R)-hydroxymellein Antimicrobial  [154] 
   4,8-dihydroxy-3,4-
dihydro-2H-naphthalen-1-
one 
Antimicrobial [154] 
Order 
Spirophorida 
Family 
Tetillidae 
Craniella 
australiensis (South 
China Sea)  
Streptomyces sp. DA11 
(Actinobacteria) 
Chitinase Antifungal  [163] 
Order 
Verongida 
Family 
Aplysinellidae 
Suberea clavata 
(Great Barrier Reef, 
Australia)  
Salinospora sp. 
(Actinobacteria) 
Rifamycin B  Antibiotic  [164,166] 
   Rifamycin  SV  Antibiotic  [164,166] 
Aplysinidae  Aplysina aerophoba 
(Mediterranean coast, 
France)  
 Bacillus subtilis A184 
(Firmicutes) 
Surfactin , iturin and 
fengycin 
Antifungal, 
antibacterial, hemolytic 
[170] 
  Bacillus subtilis A190 
(Firmicutes) 
Surfactin Antifungal, hemolytic  [170] 
 Bacillus  subtilis  A202 
(Firmicutes) 
Iturin Antifungal,  hemolytic  [170] 
 Bacillus  pumilus  A586 
(Firmicutes) 
Pumilacidin containing β-
hydroxy fatty- acid 
Antibacterial [170] 
Aplysina aerophoba 
(Mediterranean Sea)  
Microsphaeropsis sp. 
(Anamorphic fungus) 
10-Hydroxy-18-methoxyl-
betaenone 
Protein Kinase C ε 
inhibitor 
[174] 
Aplysina aerophoba 
( Banyuls sur Mer)  
Bacillus sp. SB8 (Firmicutes)   Unidentified compound  Antibacterial  [41] 
Bacillus sp. SB17 (Firmicutes)  Unidentified compound  Antibacterial  [41] 
  Micrococcus sp. SB58 
(Actinobacteria) 
Unidentified compound  Antibacterial  [41] 
  Enterococcus sp. SB91 
(Firmicutes) 
Unidentified compound  Antibacterial  [41] 
  Arthrobacter sp. SB95 
(Actinobacteria) 
Unidentified compound  Antibacterial  [41] 
  Unidentified bacteria SB122  Unidentified compound  Antibacterial  [41] 
  Unidentified bacteria SB144  Unidentified compound  Antibacterial  [41] 
  α-Proteobacteria SB6  Unidentified compound  Antibacterial  [41] 
  α-Proteobacteria SB55  Unidentified compound  Antibacterial  [41] 
  α-Proteobacteria SB63  Unidentified compound  Antibacterial  [41] 
  α-Proteobacteria SB89  Unidentified compound  Antibacterial  [41] 
  α-Proteobacteria SB156  Unidentified compound  Antibacterial  [41] 
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    α-Proteobacteria SB197  Unidentified compound  Antibacterial  [41] 
α-Proteobacteria SB202  Unidentified compound  Antibacterial  [41] 
α-Proteobacteria SB207  Unidentified compound  Antibacterial  [41] 
α-Proteobacteria SB214  Unidentified compound  Antibacterial  [41] 
Vibrio halioticoli SB177 (γ-
Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB181  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB182  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB183  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB185  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseud-oalteromonas sp. SB186 (γ-
Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB192  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB194 
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB200  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB208  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-alteromonas sp. SB213  
(γ-Proteobacteria) 
Unidentified compound  Antibacterial  [41] 
Pseudo-
ceratinidae 
Pseudoceratina 
purpurea (Fiji) 
Metarrhizium sp. 001103 
(Ascomycota (fungus)) 
 
Destruxin A  Antitumor  [90] 
     Destruxin B2  Antitumor  [90] 
     Desmethyl B  Antitumor  [90] 
     E chlorohydrin  Antitumor  [90] 
     E2 chlorohydrin  Antitumor  [90] 
Class: Calcarea 
Order 
Clathrinida 
Family 
Leucettidae 
Leucetta 
microraphis 
(Great Barrier Reef, 
Australia)  
Unidentified cyanobacteria  Leucamide A  Antitumor  [120] 
Unidentified sponges 
Unidentified 
 
Unidentified 
(Venezuela)  
Emericella variecolor (Ascomycota 
(fungus)) 
Varitriol Anticancer [176] 
    Varixanthone Antimicrobial  [176] 
Unidentified   Streptomyces sp. Ni-80  
(Actinobacteria) 
Urauchimycin A   Antibiotic [177] 
    Urauchimycin B  Antibiotic [177] Mar. Drugs 2010, 8                 
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 Unidentified  (Harrington 
Point, Otago Harbor, 
New Zealand)  
Microascus longirostris SF-73 
(Ascomycota (fungus)) 
Cathestatin A  Cysteine 
protease inhibitor 
[178] 
   Cathestatin  B  Cysteine 
protease inhibitor 
[178] 
   Cathestatin  C  Cysteine 
protease inhibitor 
[178] 
Unidentified 
(Pohnpei, The federated 
state of Micronesia) 
Aspergillus ostianus 01F313 
(Ascomycota (fungus)) 
8-chloro-9-hydroxy-
8,9-deoxyasperlactone 
Antibacterial [179] 
   9-chloro-8-hydroxy-
8,9-deoxyasperlactone 
Antibacterial [179] 
   9-chloro-8-hydroxy-
8,9-deoxyaspyrone 
Antibacterial [179] 
   Aspinonene  Antileukemic  [48,180] 
   Dihydroaspyrone  Antileukemic [48,180] 
   Aspergillide  A  Antileukemic  [48,181] 
   Aspergillide  B  Antileukemic  [48,181] 
   Aspergillide  C  Antileukemic  [48,181] 
  Cryptosphaeria eunomia 
(Ascomycota (fungus)) 
Diaporthein A  Antibacterial  [48,182] 
   Diaporthein  B  Antibacterial  [48,182] 
3. Discussion 
Sponge-microbial associations which synthesize clinically significant bioactive compounds have 
been discovered so far from geographically different regions such as Great Barrier Reef of Australia, 
South China Sea, Mediterranean Sea, Indonesia, Papua New Guinea, Indo-Pacific  region  etc.  
(Table 2). The review brings out the fact that members of the class Demospongiae are the richest 
producer of pharmacologically significant bioactive compounds in association with microbes. Out of 
92 families under class Demospongiae, 26 familes have been identified to produce medicinally 
important bioactive compounds of microbial origin. They includes Ancorinidae, Chondrillidae, 
Darwinellidae, Dysideidae, Irciniidae, Spongiidae, Thorectidae, Spirastrellidae, Suberitidae, 
Axinellidae, Halichondriidae, Callyspongiidae, Chalinidae, Niphatidae, Petrosiidae, Neopeltidae, 
Theonellidae, Acarnidae, Raspailiidae, Isodictyidae, Mycalidae, Myxillidae, Tetillidae, Aplysinellidae, 
Aplysinidae and Pseudoceratinidae. The major orders which contribute maximum to the compound 
production are Halichondrida, Dictyoceratida and Poecilosclerida. Families which belong to the order 
Halichondrida such as Axinellidae and Halichondriidae are more influenced by microbes in the 
production of secondary metabolites. The microbial associates of halichondrid comprises broad 
spectrum of bacteria, actinobacteria, fungi and micro algae. Association of these microbes with 
different species of halichondrid sponges have been shown to be the real source of bioactive 
compounds exhibiting significant therapeutic effects. These compounds include alteramide, 
trichodenone A-C, gymnastatins A-C (antileukemic) YM-202204, YM-266183 and YM-266184 Mar. Drugs 2010, 8                 
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(antibiotics). Apart from these, species belonging to the families Chalinidae and Petrosiidae of the 
order Haplosclerida, Darwinellidae of the order Dendroceratida are also rich sources of bioactive 
compounds of microbial origin. Only one family from the class Calcarea has been identified as a 
source of pharmacologically significant bioactive compounds of microbial origin. There are no reports 
in the literature regarding isolation of microbial originated therapeutic compounds from the class 
Hexactinellida. 
Figure 1. Percentage distribution of compounds produced by different orders of 
Demospongiae in association with microbes. 
 
Some of the compounds produced by microbes in association with sponge orders such as 
Hadromerida, Haplosclerida and Verongida have not been characterized and therefore have not been 
included in the above figure.  
The major groups of microorganisms recognized from this review as possible contributors of 
pharmacologically relevant secondary metabolites of sponges includes α,  β,  γ,  δ- Proteobacteria, 
Firmicutes, Actinobacteria, Cyanobacteria and Fungi. Interestingly, the members of the fungal genus 
Aspergillus, which is ubiquitous in terrestrial, is also the principle source of bioactive compounds in 
marine sponges. Out of more than 680 fungal strains isolated worldwide from 16 sponge species, 
majority belong to the genera Aspergillus and Penicillium [184].The Fusarium genus is also 
considered as a potential candidate for the production of novel antibiotics [44]. Even though most of 
the the sponge-microbial association is very specific for the production of a particular compound, a 
few compounds have also been isolated from free living and associated microbes in marine and 
terrestrial ecosystems. Tricyclic sesquiterpene coriolin B (anticancer) has been isolated from a marine 
fungus of the class Hyphomycetes in Jaspis. aff. johnstoni as well as from the terrestrial wood rotting 
basidiomycete Coriolus consors [45]. Both the antimycobacterial compounds diaporthein A and B 
were isolated from the terrestrial fungus Diaporthe sp. and the marine fungus Cryptosphaeria eunomia 
associated with an unidentified sponge [48,182,183]. Polyketides such as decumbenones A and B were 
earlier isolated from the soil fungus Penicillium decumbens and later from Aspergillus versicolor Mar. Drugs 2010, 8                 
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associated with Petrosia sp. [139–141]. The antibacillus peptide antibiotic, andrimid was isolated from 
Vibrio sp. M 22-1 associated with the sponge Hyatella sp. and also from a symbiotic Enterobacter sp. 
of the brown plant-hopper Nilaparvata lugens [68]. Some sponges always harbour a particular genera 
or species of microorganism and consistently produce specific group of compounds. The association of 
the tropical marine shallow water sponge Lamellodysidea herbacea with cyanobacterium Oscillatoria 
spongeliae, is one such example which produces chlorinated diketopiperazines [58]. Similarly, the 
symbiotic microbes of Dysidea sp. consistently synthesize brominated diphenyl ethers [60]. Likewise, 
irrespective of the geographical region  the antileukemic compound asperazine is produced by 
Aspergillus niger from two different Hyrtios species. Also, the antileukemic and antitumor compound 
roridin A is produced by Myrothecium sp. present in Spongia sp. of Hawaii and Axinella sp. of South 
China Sea [70,74,76,83]. 
Figure 2. Percentage distribution of compounds produced by bacterial and fungal 
associates in sponges. 
 
Figure 3. Percentage distribution of compounds produced by associated bacteria- phylum wise. 
 
 Mar. Drugs 2010, 8                 
 
1450
Figure 4. Percentage distribution of compounds produced by associated fungi-division wise. 
 
Figures 2, 3 and 4 show the percentage distribution of clinically active compounds obtained from 
bacteria and fungi. Even though the number of bacterial isolates exhibiting clinical activities are more 
than fungi, many of the compounds produced by bacteria are not yet characterized. Figures 2 and 3 
could be altered later once those compounds are characterized. Phylum Actinobacteria dominates in 
the production of therapeutic compounds followed by Proteobacteria. Bioactive potential of firmicutes 
and cyanobacteria is yet to be explored. Among fungi, Ascomycota is a predominant producer of 
bioactive molecules and Deuteromycota is also a potential group exhibiting bioactivity. 
A wide range of chemical and functional diversity has been observed among bioactive compounds. 
Of the various chemical classes of compounds, polyketides, alkaloids, fatty acids, peptides and 
terpenes are the most abundant ones. Majority of them show antimicrobial, antitumor and anticancer 
properties. Bacterial and fungal associates in the order Dictyoceratida are found to synthesize 
antiangiogenic, anticancer, antiHIV, antitumor as well as antimicrobial compounds 
[15,40,57,59,61,62,64–66,69]. Another noticeable fact is the discovery of an actinobacterial strain 
(Nocardiopsis dassonvillei MAD08) from the sponge Dendrilla nigra of the family Darwinellidae 
from southwest coast of India (Table 3). This particular strain was able to produce compounds 
exhibiting antimicrobial, antioxidant, hypocholesterolemic, nematicidal, antiandrogenic, hemolytic, 
anti-inflammatory and anticancer properties. Of the various compounds produced by this strain, 
hexadecanoic acid- methyl ester, n-hexadecanoic acid, hexadecanoic acid-ethyl ester, 9-octadecenoic 
acid (Z)-methyl ester, oleic acid and (E)-9-octadecenoic acid-ethyl ester have been shown to be 
multifunctional [54]. Similarly the fungal strain Gymnascella dankaliensis OUPS-N134 from 
Halichondria japonica was very potent and produced 12 antileukemic compounds [78,102–109].  
Table 3. Chemical diversity of therapeutics produced by sponge-microbe associations. 
Category Chemical  diversity 
Antiandrogenic  Fattyacid esters, fatty acids 
Antiangiogenic Quinone 
Anticancer  Quinone, steroid, fatty acid esters, fatty acids, diketopiperazine, alkaloid, terpenes, terpenoids, 
trichoverroids, prodigiosin derivative Mar. Drugs 2010, 8                 
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AntiHIV Quinolone  derivative 
Anti-inflammatory  Fatty acid esters, fatty acid 
Antimalarial  Alkaloid, quinolone derivative 
Antimicrobial Polyketide,  glycopeptides,  α-pyrone derivative, peptide, protein, antimycin, lipopeptides, 
polybrominated biphenyl ether, cyclic depsipeptide, terpenes, pentaketides, furan carboxylic 
acid, alkaloid, diketopiperazine, anthraquinone, chromones, steroid, lactone, quinolone 
derivative, trisindole derivative, macrolactam, ethers, phenol derivative 
Antiinfective Polyketides 
Antioxidant  Fatty acid esters, fatty acid, carotenoic acid 
Anti-respiratory Terpenoids 
Antitumor  Diglucosyl-glycerol, polyketides, alkaloids, cyclopeptides, glycoglycerolipid, benzoic acid 
derivative, terpenoids, terpenes, trichoverroids 
Hemolytic  Fatty acid ester, fatty acids 
Hypocholesterolemic  Fatty acid ester, fatty acids 
Immunosupressant Mycophenolic  acid 
Melanin inhibitor  Polyketide 
Nematicide  Fatty acid ester, fatty acids 
Neuroactive Unknown 
Neuroprotective Dihydropyridine 
Table 4. Microbial groups in various orders of sponges producing functionally diverse 
therapeutics. 
Symbiont    Sponge order    Compound fuction 
 
Bacteria    Dendroceratida    Antiandrogenic 
Bacteria    Dictyoceratida, Hadromerida    Antiangiogenic 
Bacteria 
 
  Halichondrida, Dendroceratida, 
Poecilosclerida 
  Anticancer 
 
Fungi    Dictyoceratida, Halichondrida, 
Haplosclerida, Poecilosclerida 
Bacteria    Lithistida     AntiHIV 
Fungi    Dictyoceratida 
Fungi    Chondrosida    Anti-infective 
Bacteria    Dendroceratida    Ant-inflammatory 
Bacteria    Lithistida, Haplosclerida    Antimalarial 
Bacteria 
 
 
  Astrophorida, Dendroceratida 
Dictyoceratida, Hadromerida, 
Haplosclerida, Halichondrida, 
Lithistida, Poecilosclerida, 
Spirophorida, Verongida 
  Antimicrobial 
 
Fungi 
 
  Hadromerida, Halichondrida, 
Haplosclerida, Poecilosclerida 
Bacteria    Dendroceratida, Halichondrida    Antioxidant Mar. Drugs 2010, 8                 
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Fungi    Haplosclerida    Anti-respiratory 
Bacteria    Clathrinida, Halichondrida, 
Haplosclerida, Lithistida 
  Antitumor 
 
Fungi    Astrophorida, Dictyoceratida, 
Poecilosclerida, Verongida 
Bacteria    Hadromerida, Dendroceratida    Hemolytic 
Bacteria    Dendroceratida    Hypocholesterolemic 
Fungi    Haplosclerida    Immunosuppressant 
Fungi    Haplosclerida    Melanin inhibitor 
Bacteria    Dendroceratida    Nematicide 
Bacteria    Halichondrida    Neuroactive 
Fungi    Halichondrida    Neuroprotective 
Some of the drugs available in the market, which were previously isolated from various terrestrial 
microbial genera were also detected in the marine counterparts associated with the sponges. A 
fungistatic drug, griseofulvin used for dermatophytoses has been isolated from various terrestrial and 
marine strains of Penicillium. This drug has also been reported from Penicillium symbiont of the 
Mediterranean sponge Axinella verrucosa [85,186]. Similarly, a well known immunosuppressive and 
antibiotic drug, mycophenolic acid which was produced by various strains of Penicillium including 
Penicillium  stoloniferum and Penicillium roqueforti has also been isolated from Penicillium 
brevicompactum associated with the sponge Petrosia ficiformis [130,187,188]. Thus, the bioactive 
potential of the genus Penicillium either marine or terrestrial origin, free living or symbiotic makes it a 
worthy candidate for understanding the microbe-sponge association and harnessing the bioactive 
compounds.  
4. Ecological and Cultural Aspects of Sponge Symbionts 
To date, the primary target for marine bioprospecting has been tropical seas particularly coral reefs 
and other highly diverse ecosystems such as mangroves and seagrass because they host a high level of 
biodiversity and often face intense competition for space, leading to a chemical warfare among the 
sessile organisms. It was proven extremely difficult and in some cases impossible to provide sufficient 
quantity of these substances from invertebrates. The reason was due to the limited quantity of the 
compound, or still due to limited number of organisms producing the compound. Geographical, 
seasonal or sexual variations in the amount and nature of secondary metabolites could also be the other 
reasons for not consistently getting the required quantity of the compound. Marine invertebrates which 
are abundant in the Indo-Pacific regions, are rich in secondary metabolites and are becoming targets of 
continuing search for bioactive compounds [189]. The China Sea has become an important source of 
marine natural compounds since 2001 [190]. Among metazoans, the phylum Porifera contains the taxa 
which produce the highest diversity of secondary metabolites [191].  
With some exceptions, sponge-associated microbial communities appear to be relatively stable with 
time and space [192]. With respect to temporal variability, the fluctuation of microbial communities in Mar. Drugs 2010, 8                 
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Aplysina aerophobha (an aquarium maintained specimen), Geodia barrette (Cultivated explant), 
temperate Australian sponges such as Callyspongia sp., Stylinos sp. and Cymbastela concentrica were 
detected to be low with no evidence of major seasonal changes [169,193,194]. In contrast to these 
studies, the bacterial community abundant in the North Sea sponge Halichondria panacea was found 
to vary considerably over a 10 month period [195]. Spatial variability could be ascribed to difference 
in microbiota within and among individuals which are separated by geographical barriers [194–196]. 
Marked differences were evident between the microbial communities inhabiting the outer (cortex) and 
inner (endosome) tissue in the Mediterranean sponge Tethya aurantium [197]. Contrary to this, 
Antarctic sponges such as Homaxinella balfourensis, Kirkpatrickia varialosa, Latrunculia apicalis, 
Mycale acerata and Sphaerotylus antarcticus collected from different sampling sites separated by 10 
km were found to possess highly consistent bacterial communities. It highlights that site variability 
does not affect bacterial community composition in Antarctic sponges, but is highly consistent within a 
particular species [195]. Another study by Taylor et al. [198], showed that bacterial communities 
associated with temperate and tropical population of Cymbastela concentrica along the eastern 
Australian coast vary substantially.  
Seasonal changes in the production of bioactive compounds by sponges are poorly understood. 
Seasonal fluctuations occurring in temperate seas impose significant alterations on the biology of the 
organism [199]. Seasonal changes, both qualitative and quantitative, have been observed in bioactive 
compound production in the sponge Crambe crambe from Mediterranean Sea. More importantly, high 
intra individual variability has also been observed. High toxicity in the producer organism during 
autumn may be a defense mechanism to counter increased growth of competing animal species at the 
end of summer. A decrease in toxicity in the months preceding April could be due to the reproductive 
rhythm. Energy diversion towards reproduction may explain the decrease in toxic metabolite 
production [200]. It was also found that non-polar fraction of the crude extract obtained from 
associated bacteria of the sponge Ircinia ramosa possessed strong antibacterial activity in summer. 
During winter season, activity was detected in the polar fraction and it was comparatively weaker than 
the observed activity in non-polar fraction during summer. This give insight in to the assumption that 
chemistry and production rate of metabolites from sponges or associated bacteria could be governed by 
environmental conditions [201]. More studies are being done to show that microbes are the real source 
of many of the bioactive compounds in sponges. Future efforts may throw more light on seasonal 
effects of bioactive compound production by these associates. 
The occurrence of important metabolites within sponge-associated bacteria opens up the possibility 
of providing a continuous supply of the biologically active compounds by laboratory cultivation of the 
producer [202]. It would seem a logical step trying to isolate and cultivate putative bacterial producers 
outside invertebrate hosts in order to set up a sustainable and manageable source of pharmacologically 
active compounds. Even if microbial populations can be successfully separated from the hosts, the 
undefined metabolic factors of the host may render it difficult for the symbiont to grow ex hospite [82]. 
Many bacterial inhabitants in sponges appear to be highly selective with regard to culture media and 
conditions which probably reflect their evolutionary adaptation to the conditions provided by the host. 
Attempts to culture the theopaulamide producing bacteria from the sponge Theonella swinhoei have 
failed so far [203]. A notable exception is an anti-infective alkaloid manzamine A, which was 
successfully obtained from the culture of bacterium Micromonospora sp. of the deep-water Indonesian Mar. Drugs 2010, 8                 
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sponge  Acanthostrongylophora  sp. [13]. Another possibility is to grow the entire sponge and its 
microbial community in self-contained aquaculture systems for the economic, sustainable supply of 
important metabolites. The advantage of the latter strategy compared with growth of sponges in the 
wild or in open-water mariculture system is the possibility of better control of environmental 
conditions such as temperature, light, food supply and possibly precursors of important bioactive 
metabolites. In addition, aquaculture of sponges may provide less perturbation of the bacterium-host 
association over growth of bacterial ‘producers’ strains in pure culture which could be very important 
for maintaining production of compounds of interest [62]. 
It is hypothesized that antagonism, polyketide synthase genes and PLA2 are the key functional 
precursors of secondary metabolite synthesis and/or host defense of marine sponges. The study of 
metabolite-related genes of microorganisms associated with sponges may give insight into the origin 
of sponge-derived natural products. Polyketides, comprising a large and structural diverse family of 
bioactive natural products are one of the most important classes of marine natural compounds [190]. 
Polyketide synthase genes of host sponge and associated bacteria are predicted to be biosynthetic 
modules of polyketide analogues as well as phospholipases [51]. The PKS gene-based molecular 
approach can be applied to efficient screening of strains of pharmaceutical value and prediction of 
related compounds. This strategy has been employed to discover the efficiency of polyketide 
production in Firmicutes especially Bacillus, Actinobacteria and Proteobacteria isolated from sponges 
of the South China Sea [190]. Isolation and culture of symbiotic microorganisms as producers of 
secondary metabolites as well as transfer of symbiont biosynthetic genes into cultivable bacteria are 
subjects of ongoing research [149,204]. Even if compounds or compound groups appear exclusive for 
a particular taxon, they are not necessarily homologous and derived from a common ancestor and 
therefore do not necessarily reflect a genealogical relationship. They might originate from different 
precursors and biochemical pathways [203]. Rajdasa et al. [2], highlighted the repetitive PCR method 
as a powerful tool in estimating the richness of secondary metabolite producers among colonizers of 
sponge Haliclona sp. and this approach may be useful in studying the diversity of other sponge-
associated microorganisms. 
5. Conclusions 
Sponge-microbial associations are found to be very specific in the production of particular bioactive 
compounds. However, the mutual mechanism between host and the microbial associate, in compound 
production is not well understood. The easiest and best way for commercial production of these 
compounds are either by culturing the host and/or the associated microbe under controlled conditions. 
But, the ability of the symbiont to produce the compound consistently for several generation in culture 
media has to be tested and standardized. Moreover, there is a need for quantifying the role of sponge 
ecology in orchestrating the production of specific compounds. Metagenomic approaches are also 
being increasingly used for targeting putative genes encoding potential metabolites in uncultured 
microbial biota. These approaches would help in delineating the contribution of either the host or 
microbial associate or both partners in the production of metabolites. A few compounds have been 
found to be produced both in terrestrial and marine ecosystems by different groups of host-symbiont 
association. This suggests the possibility of horizontal gene transfer through evolution. Discovery of Mar. Drugs 2010, 8                 
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potent microbial associates producing therapeutic compounds has opened up a new era in marine 
pharmacology. Understanding the optimum ecological conditions which drives the sustainable 
production of bioactive compounds from sponges and their microbial associates would help in 
formulating various production strategies. Adopting different cultivation strategies and metagenomic 
approaches would be the need of the hour in discovering new genes, enzymes and natural products and 
in enhancing the commercial production of marine drugs. 
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